
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B371D926459733C371D0053D2EAAE.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="peerj">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6482939/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PeerJ">
<meta name="citation_title" content="Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer">
<meta name="citation_author" content="Arianna Nicolussi">
<meta name="citation_author_institution" content="Department of Experimental Medicine, University of Roma “La Sapienza”, Roma, Italy">
<meta name="citation_author" content="Francesca Belardinilli">
<meta name="citation_author_institution" content="Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy">
<meta name="citation_author" content="Yasaman Mahdavian">
<meta name="citation_author_institution" content="Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy">
<meta name="citation_author" content="Valeria Colicchia">
<meta name="citation_author_institution" content="Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy">
<meta name="citation_author" content="Sonia D’Inzeo">
<meta name="citation_author_institution" content="Department of Experimental Medicine, University of Roma “La Sapienza”, Roma, Italy">
<meta name="citation_author_institution" content="U.O.C. Microbiology and Virology Laboratory, A.O. San Camillo Forlanini, Roma, Italy">
<meta name="citation_author" content="Marialaura Petroni">
<meta name="citation_author_institution" content="Istituto Italiano di Tecnologia, Center for Life Nano Science@Sapienza, Roma, Italy">
<meta name="citation_author" content="Massimo Zani">
<meta name="citation_author_institution" content="Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy">
<meta name="citation_author" content="Sergio Ferraro">
<meta name="citation_author_institution" content="Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy">
<meta name="citation_author" content="Virginia Valentini">
<meta name="citation_author_institution" content="Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy">
<meta name="citation_author" content="Laura Ottini">
<meta name="citation_author_institution" content="Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy">
<meta name="citation_author" content="Giuseppe Giannini">
<meta name="citation_author_institution" content="Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy">
<meta name="citation_author_institution" content="Istituto Pasteur-Fondazione Cenci Bolognetti, Roma, Italy">
<meta name="citation_author" content="Carlo Capalbo">
<meta name="citation_author_institution" content="Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy">
<meta name="citation_author" content="Anna Coppa">
<meta name="citation_author_institution" content="Department of Experimental Medicine, University of Roma “La Sapienza”, Roma, Italy">
<meta name="citation_publication_date" content="2019 Apr 22">
<meta name="citation_volume" content="7">
<meta name="citation_firstpage" content="e6661">
<meta name="citation_doi" content="10.7717/peerj.6661">
<meta name="citation_pmid" content="31065452">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6482939/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6482939/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6482939/pdf/peerj-07-6661.pdf">
<meta name="description" content="Conventional methods used to identify BRCA1 and BRCA2 germline mutations in hereditary cancers, such as Sanger sequencing/multiplex ligation-dependent probe amplification (MLPA), are time-consuming and expensive, due to the large size of the genes. ...">
<meta name="og:title" content="Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Conventional methods used to identify BRCA1 and BRCA2 germline mutations in hereditary cancers, such as Sanger sequencing/multiplex ligation-dependent probe amplification (MLPA), are time-consuming and expensive, due to the large size of the genes. ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6482939/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="6482939">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.7717/peerj.6661"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/peerj-07-6661.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC6482939%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/6482939/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/6482939/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC6482939/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-peerj.png" alt="PeerJ logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PeerJ" title="Link to PeerJ" shape="default" href="http://peerj.com/life-environment" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PeerJ</button></div>. 2019 Apr 22;7:e6661. doi: <a href="https://doi.org/10.7717/peerj.6661" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.7717/peerj.6661</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22PeerJ%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PeerJ%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PeerJ%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PeerJ%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Next-generation sequencing of <em>BRCA1</em> and <em>BRCA2</em> genes for rapid detection of germline mutations in hereditary breast/ovarian cancer</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nicolussi%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Arianna Nicolussi</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Arianna Nicolussi</span></h3>
<div class="p">
<sup>1</sup>Department of Experimental Medicine, University of Roma “La Sapienza”, Roma, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nicolussi%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Arianna Nicolussi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Belardinilli%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Francesca Belardinilli</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Francesca Belardinilli</span></h3>
<div class="p">
<sup>2</sup>Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Belardinilli%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Francesca Belardinilli</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mahdavian%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Yasaman Mahdavian</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Yasaman Mahdavian</span></h3>
<div class="p">
<sup>2</sup>Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mahdavian%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yasaman Mahdavian</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Colicchia%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Valeria Colicchia</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Valeria Colicchia</span></h3>
<div class="p">
<sup>2</sup>Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Colicchia%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Valeria Colicchia</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22D%E2%80%99Inzeo%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Sonia D’Inzeo</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Sonia D’Inzeo</span></h3>
<div class="p">
<sup>1</sup>Department of Experimental Medicine, University of Roma “La Sapienza”, Roma, Italy</div>
<div class="p">
<sup>3</sup>U.O.C. Microbiology and Virology Laboratory, A.O. San Camillo Forlanini, Roma, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22D%E2%80%99Inzeo%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sonia D’Inzeo</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Petroni%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Marialaura Petroni</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Marialaura Petroni</span></h3>
<div class="p">
<sup>4</sup>Istituto Italiano di Tecnologia, Center for Life Nano Science@Sapienza, Roma, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Petroni%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marialaura Petroni</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zani%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Massimo Zani</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Massimo Zani</span></h3>
<div class="p">
<sup>2</sup>Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zani%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Massimo Zani</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ferraro%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Sergio Ferraro</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Sergio Ferraro</span></h3>
<div class="p">
<sup>2</sup>Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ferraro%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sergio Ferraro</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Valentini%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Virginia Valentini</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Virginia Valentini</span></h3>
<div class="p">
<sup>2</sup>Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Valentini%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Virginia Valentini</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ottini%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Laura Ottini</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Laura Ottini</span></h3>
<div class="p">
<sup>2</sup>Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ottini%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Laura Ottini</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Giannini%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Giuseppe Giannini</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Giuseppe Giannini</span></h3>
<div class="p">
<sup>2</sup>Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy</div>
<div class="p">
<sup>5</sup>Istituto Pasteur-Fondazione Cenci Bolognetti, Roma, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Giannini%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Giuseppe Giannini</span></a>
</div>
</div>
<sup>2,</sup><sup>5,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Capalbo%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Carlo Capalbo</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Carlo Capalbo</span></h3>
<div class="p">
<sup>2</sup>Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Capalbo%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Carlo Capalbo</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Coppa%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Anna Coppa</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Anna Coppa</span></h3>
<div class="p">
<sup>1</sup>Department of Experimental Medicine, University of Roma “La Sapienza”, Roma, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Coppa%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anna Coppa</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<div class="cg p">Editor: <span class="name western">D Gareth Evans</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff-1">
<sup>1</sup>Department of Experimental Medicine, University of Roma “La Sapienza”, Roma, Italy</div>
<div id="aff-2">
<sup>2</sup>Department of Molecular Medicine, University of Roma “La Sapienza”, Roma, Italy</div>
<div id="aff-3">
<sup>3</sup>U.O.C. Microbiology and Virology Laboratory, A.O. San Camillo Forlanini, Roma, Italy</div>
<div id="aff-4">
<sup>4</sup>Istituto Italiano di Tecnologia, Center for Life Nano Science@Sapienza, Roma, Italy</div>
<div id="aff-5">
<sup>5</sup>Istituto Pasteur-Fondazione Cenci Bolognetti, Roma, Italy</div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2018 Dec 7; Accepted 2019 Feb 19; Collection date 2019.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2019 Nicolussi et al.</div>
<p>This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC6482939  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31065452/" class="usa-link">31065452</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p>Conventional methods used to identify <em>BRCA1</em> and <em>BRCA2</em> germline mutations in hereditary cancers, such as Sanger sequencing/multiplex ligation-dependent probe amplification (MLPA), are time-consuming and expensive, due to the large size of the genes. The recent introduction of next-generation sequencing (NGS) benchtop platforms offered a powerful alternative for mutation detection, dramatically improving the speed and the efficiency of DNA testing. Here we tested the performance of the Ion Torrent PGM platform with the Ion AmpliSeq BRCA1 and BRCA2 Panel in our clinical routine of breast/ovarian hereditary cancer syndrome assessment.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p>We first tested the NGS approach in a cohort of 11 patients (training set) who had previously undergone genetic diagnosis in our laboratory by conventional methods. Then, we applied the optimized pipeline to the consecutive cohort of 136 uncharacterized probands (validation set).</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p>By minimal adjustments in the analytical pipeline of Torrent Suite Software we obtained a 100% concordance with Sanger results regarding the identification of single nucleotide alterations, insertions, and deletions with the exception of three large genomic rearrangements (LGRs) contained in the training set. The optimized pipeline applied to the validation set (VS), identified pathogenic and polymorphic variants, including a novel <em>BRCA2</em> pathogenic variant at exon 3, 100% of which were confirmed by Sanger in their correct zygosity status. To identify LGRs, all negative samples of the VS were subjected to MLPA analysis.</p></section><section id="sec4"><h3 class="pmc_sec_title">Discussion</h3>
<p>Our experience strongly supports that the Ion Torrent PGM technology in <em>BRCA1</em> and <em>BRCA2</em> germline variant identification, combined with MLPA analysis, is highly sensitive, easy to use, faster, and cheaper than traditional (Sanger sequencing/MLPA) approaches.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> Next-generation sequencing, Hereditary breast/ovarian cancer, DNA testing, BRCA1, BRCA2</p></section></section><section id="sec5"><h2 class="pmc_sec_title">Introduction</h2>
<p>Inherited mutations in highly penetrant <em>BRCA1</em> and <em>BRCA2</em> genes occur in about 5–10% of breast and ovarian cancer disease (<a href="#ref-1" class="usa-link" aria-describedby="ref-1">Foulkes, 2008</a>). A recent prospective cohort study has estimated that the cumulative risks of breast cancer to age 80 years was 72% for <em>BRCA1</em> and 69% for <em>BRCA2</em> carriers (<a href="#ref-2" class="usa-link" aria-describedby="ref-2">Kuchenbaecker et al., 2017</a>). A large mutation spectrum has been reported for these genes, as recently revised (<a href="#ref-3" class="usa-link" aria-describedby="ref-3">Rebbeck et al., 2018</a>). The contribution of low-penetrance and risk-modifying genetic polymorphisms to a more appropriate assessment of individual risk is also emerging (<a href="#ref-4" class="usa-link" aria-describedby="ref-4">Couch et al., 2012</a>; <a href="#ref-5" class="usa-link" aria-describedby="ref-5">Ottini et al., 2013</a>; <a href="#ref-6" class="usa-link" aria-describedby="ref-6">Kuchenbaecker et al., 2014</a>; <a href="#ref-7" class="usa-link" aria-describedby="ref-7">Peterlongo et al., 2015</a>).</p>
<p>Direct Sanger sequencing represented the most common method for over two decades to identify single nucleotide alterations, insertions, and deletions of <em>BRCA1</em> and <em>BRCA2</em> in the clinical practice. Large genomic alterations may be detected by the multiplex ligation-dependent probe amplification (MLPA) assay. Sanger sequencing and MLPA are to date considered the gold standard methods to determine the <em>BRCA1</em> and <em>BRCA2</em> mutation status. However, the big size (5,592 bp and 10,257 bp, respectively), the content in homopolymeric regions and the high-allelic heterogeneity of the genes, together with the lack of mutation hot spots, made the diagnostic procedure time-consuming and costly. The recent improvements in DNA sequencing technology, and the emergence of benchtop next-generation sequencing (NGS) instruments offered a powerful alternative for mutation detection, dramatically improving the speed and the efficiency of DNA testing (<a href="#ref-8" class="usa-link" aria-describedby="ref-8">Feliubadaló et al., 2013</a>; <a href="#ref-9" class="usa-link" aria-describedby="ref-9">Yeo et al., 2014</a>; <a href="#ref-10" class="usa-link" aria-describedby="ref-10">Trujillano et al., 2015</a>). Indeed, NGS significantly speeded the reporting times of hereditary breast/ovarian cancer predisposition, important for rapid clinical management of carriers.</p>
<p>The implementation of targeted therapy in solid cancers with poly(ADP-ribose) polymerase (PARP) inhibitors (<a href="#ref-11" class="usa-link" aria-describedby="ref-11">O’Sullivan Coyne, Chen &amp; Kummar, 2015</a>; <a href="#ref-12" class="usa-link" aria-describedby="ref-12">Colicchia et al., 2017</a>; <a href="#ref-13" class="usa-link" aria-describedby="ref-13">Stewart, Pilié &amp; Yap, 2018</a>) and in particular the observation of their effectiveness in some phase 3 trials carried out in women with <em>BRCA1</em> or <em>BRCA2</em> pathogenic variants and metastatic ovarian or advanced breast cancer (<a href="#ref-14" class="usa-link" aria-describedby="ref-14">Coleman et al., 2017</a>; <a href="#ref-15" class="usa-link" aria-describedby="ref-15">Robson et al., 2017</a>; <a href="#ref-16" class="usa-link" aria-describedby="ref-16">Oza et al., 2018</a>; <a href="#ref-17" class="usa-link" aria-describedby="ref-17">Litton et al., 2018</a>), indicate <em>BRCA1</em> and <em>BRCA2</em> mutation status as a novel biomarker and highlights the importance of shortening the turn-around time (TAT) of the analysis to give results and to make possible a faster identification of carriers. To respond to the increasing request of genetic testing, NGS methods are starting to be used routinely in many molecular genetic laboratories including ours.</p>
<p>Next-generation sequencing technology is currently used with several available platforms, such as the Genome Sequencer (Roche-454 Life Sciences, Indianapolis, IN, USA), the Genome Analyzer/HiSeq/MiSeq (Illumina-Solexa, San Diego, CA, USA), Ion Torrent PGM, and Ion Proton sequencers (Thermo Fisher Scientific, Waltham, MA, USA), and the HeliScope from Helicos BioSciences (Cambridge, MA, USA) (<a href="#ref-18" class="usa-link" aria-describedby="ref-18">Voelkerding, Dames &amp; Durtschi, 2009</a>; <a href="#ref-19" class="usa-link" aria-describedby="ref-19">Rothberg et al., 2011</a>; <a href="#ref-20" class="usa-link" aria-describedby="ref-20">Wallace, 2016</a>). Key differences exist in their performance, quality of data, and throughput capacity: MiSeq had the highest throughput per run (1.6 Gb/run, 60 Mb/h) and lowest error rates, 454 GS Junior generated the longest reads (up to 600 bases) but had the lowest throughput (70 Mb/run, nine Mb/h), while Ion Torrent PGM had the highest throughput (80–100 Mb/h) (<a href="#ref-21" class="usa-link" aria-describedby="ref-21">Loman et al., 2012</a>). Ion Torrent PGM is a new sequencing platform that substantially differs from other sequencing technologies by measuring pH rather than light to detect polymerization events. It represents the first “post-light” sequencing instrument that exploits the emulsion PCR and incorporates a sequencing-by-synthesis approach. All four nucleotides are provided in a stepwise fashion during an automated run. When the nucleotides, complementary to the template are incorporated into the nascent strand, the hydrolysis of the incoming nucleotide triphosphate causes the net liberation of a single proton for each nucleotide incorporated, producing a shift in the pH of the surrounding solution detected by a modified silicon chip (<a href="#ref-19" class="usa-link" aria-describedby="ref-19">Rothberg et al., 2011</a>). Ion Torrent PGM offers three differently priced sequencing-chip reagents, giving a large flexibility in designing experiments, as a choice can be made based on the throughput required. In the present study, we evaluated the performance of the Ion Torrent PGM platform in combination with the ready-to-use Ion AmpliSeq BRCA1 and BRCA2 Panel (Life Technologies, Carlsbad, CA, USA) in the diagnostic screening for the identification of single nucleotide alterations, insertions, and deletions in <em>BRCA1</em> and <em>BRCA2</em> genes.</p></section><section id="sec6"><h2 class="pmc_sec_title">Materials and Methods</h2>
<section id="sec7"><h3 class="pmc_sec_title">Patients and DNA</h3>
<p>A retrospective cohort of 11 familial breast cancer patients, training set (TS), previously tested by Sanger sequencing for all <em>BRCA1</em> and <em>BRCA2</em> exons and by MLPA to detect large genomic rearrangements (LGRs), and a prospective consecutive cohort of 136 uncharacterized probands, validation set (VS), enrolled at the Hereditary Tumors section of Policlinico Umberto I, University La Sapienza, between July 2015 and September 2017, were analyzed. Selection criteria were as follows: (i) three or more breast cancer cases diagnosed at any age or two first-degree family members affected before 50; (ii) early onset breast cancer (&lt;35 years); (iii) breast and ovarian cancer in the same individual or two breast cancer cases and at least one ovarian cancer case, or one breast cancer case and one ovarian cancer case diagnosed before 50 in first-degree family members; (iv) male breast cancer; (v) BRCAPro5 greater than 10% (<a href="#ref-22" class="usa-link" aria-describedby="ref-22">Capalbo et al., 2006a</a>, <a href="#ref-23" class="usa-link" aria-describedby="ref-23">2006b</a>; <a href="#ref-24" class="usa-link" aria-describedby="ref-24">Coppa et al., 2014</a>).</p>
<p>Comprehensive pre-test counseling was offered to all probands and their family members and informed consent were obtained. The TS was characterized by 11 samples carrying 11 different pathogenic mutations including single nucleotide variants (SNVs), indels, and LGRs plus 37 benign variants (<a href="#table-1" class="usa-link">Table 1</a>; <a href="#supp-1" class="usa-link">Table S1</a>).</p>
<section class="tw xbox font-sm" id="table-1"><h4 class="obj_head">Table 1. <em>BRCA1</em> and <em>BRCA2</em> variants contained in the training set used for the optimization of the workflow.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
</colgroup>
<thead><tr>
<th colspan="2" rowspan="1">Variant</th>
<th rowspan="1" colspan="1">Gene</th>
<th rowspan="1" colspan="1">Effect</th>
<th rowspan="1" colspan="1">Type</th>
<th rowspan="1" colspan="1">Frequency (%)</th>
<th rowspan="1" colspan="1">Phred quality score</th>
<th rowspan="1" colspan="1">Coverage</th>
<th rowspan="1" colspan="1">Coverage var</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="1" colspan="1"><strong>DNA level</strong></td>
<td rowspan="1" colspan="1"><strong>Protein level</strong></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.5266dupC</td>
<td rowspan="1" colspan="1">p.Gln1756Profs</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">dup</td>
<td rowspan="1" colspan="1">50.7</td>
<td rowspan="1" colspan="1">4,616</td>
<td rowspan="1" colspan="1">2,362</td>
<td rowspan="1" colspan="1">1,198</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.1504_1508delTTAAA</td>
<td rowspan="1" colspan="1">p.Leu502Alafs</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">del</td>
<td rowspan="1" colspan="1">481</td>
<td rowspan="1" colspan="1">1,492.07</td>
<td rowspan="1" colspan="1">778</td>
<td rowspan="1" colspan="1">374</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.4964_4982del19</td>
<td rowspan="1" colspan="1">p.Ser1655Tyrfs</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">del</td>
<td rowspan="1" colspan="1">39.6</td>
<td rowspan="1" colspan="1">50</td>
<td rowspan="1" colspan="1">844</td>
<td rowspan="1" colspan="1">334</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.5407-?_*(1_?)del</td>
<td rowspan="1" colspan="1">p.?</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">exon 23-24del</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.5075-?_5193+?del</td>
<td rowspan="1" colspan="1">p.?</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">exon 18-19del</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="1" colspan="1">NBR2delEX1_BRCA1delEX1-2</td>
<td rowspan="1" colspan="1">p.?</td>
<td rowspan="1" colspan="1">NBR2/BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">exon 1del (NBR2) exon 1-2del (BRCA1)</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.7921_7926delGAATTTinsAG</td>
<td rowspan="1" colspan="1">p.Glu2641Argfs</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">complex</td>
<td rowspan="1" colspan="1">44.6</td>
<td rowspan="1" colspan="1">1,094.44</td>
<td rowspan="1" colspan="1">673</td>
<td rowspan="1" colspan="1">300</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.246dupA</td>
<td rowspan="1" colspan="1">p.Glu83Argfs</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">dup</td>
<td rowspan="1" colspan="1">44.7</td>
<td rowspan="1" colspan="1">409.21</td>
<td rowspan="1" colspan="1">253</td>
<td rowspan="1" colspan="1">113</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.2806_2809delAAAC</td>
<td rowspan="1" colspan="1">p.Ala938Profs</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">del</td>
<td rowspan="1" colspan="1">48.2</td>
<td rowspan="1" colspan="1">1,144.45</td>
<td rowspan="1" colspan="1">591</td>
<td rowspan="1" colspan="1">285</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.516+1G&gt;C</td>
<td rowspan="1" colspan="1">p.?</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">SNV</td>
<td rowspan="1" colspan="1">49.3</td>
<td rowspan="1" colspan="1">4,602.4</td>
<td rowspan="1" colspan="1">2,286</td>
<td rowspan="1" colspan="1">1,126</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.7007G&gt;A</td>
<td rowspan="1" colspan="1">p.Arg2336His</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">SNV</td>
<td rowspan="1" colspan="1">48.4</td>
<td rowspan="1" colspan="1">1,128.61</td>
<td rowspan="1" colspan="1">576</td>
<td rowspan="1" colspan="1">279</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/table-1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="table-1fn"><p><strong>Note:</strong></p></div>
<div class="fn" id="table-1fn1"><p>Abbreviations: del, deletion; dup, duplication; SNV, single nucleotide variant; Phred quality score: probability of incorrect call.</p></div>
</div></section><p>Genomic DNA was extracted from peripheral blood samples using a commercial kit (QIAamp Blood Kit, Qiagen, Valencia, CA, USA) according to the manufacturer’s instructions. All investigations were approved by Ethics Committee of the University of Roma “La Sapienza” (Prot.: 88/18; RIF.CE:4903, 31-01-2018) and conducted according to the principles outlined in the declaration of Helsinki.</p></section><section id="sec8"><h3 class="pmc_sec_title">Ion Torrent PGM library preparation</h3>
<p>The entire coding regions of the <em>BRCA1</em> and <em>BRCA2</em> genes were amplified using the Ion AmpliSeq BRCA1 and BRCA2 Panel (Life Technologies, Carlsbad, CA, USA) consisting of three primer pools, covering the target regions in 167 amplicons, including all exons and 10–20 bp of intronic flanking sequences, for both genes. Ion Torrent adapter-barcode ligated libraries were generated using Ion AmpliSeq™ Library Kit 2.0 (Applied Biosystems, Houston, TX, USA; Life Technologies, Carlsbad, CA, USA) and Ion Xpress™ Barcode Adapter 1-16 Kit (Applied Biosystems, Houston, TX, USA; Life Technologies, Carlsbad, CA, USA) according to the manufacturer’s procedures to obtain 200-bp PCR fragments flanked by adaptor and barcode sequences, allowing sequencing and sample identification, respectively. In brief, DNA concentration was measured with Qubit™ dsDNA HS Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA) and Qubit® Fluorometer (Thermo Fisher Scientific, Waltham, MA, USA). Ten ng of each genomic DNA sample was amplified, using Ion AmpliSeq™ HiFi Master Mix (Applied Biosystems, Houston, TX, USA; Life Technologies, Carlsbad, CA, USA) and Ion AmpliSeq <em>BRCA1</em> and <em>BRCA2</em> Community Panel primer pools (3 pools), for 2 min at 99 °C, followed by 19 two-step cycles of 99 °C for 15 s and 60 °C for 4 min, ending with a holding period at 10 °C in a GeneAmp PCR System 9700 thermocycler (Applied Biosystems, Houston, TX, USA). The amplified DNA samples were digested, then barcodes and adapters were ligated to the amplicons as previously described (<a href="#ref-25" class="usa-link" aria-describedby="ref-25">Belardinilli et al., 2015</a>) and reported in Ion AmpliSeq library preparation manual. Adaptor ligated amplicon libraries were purified with the Agencourt AMPure XP system (Beckman Coulter Genomics, Danvers, MA, USA). Following Agencourt AMPure XP purification, the concentration of the libraries was determined using the Qubit™ dsDNA HS Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA) and Qubit® Fluorometer (Thermo Fisher Scientific, Waltham, MA, USA). After quantification, each amplicon library was diluted to 50 pM and the same amount of the 12 libraries for four patients (Chip 314v2) or 24 libraries for eight patients (Chip 316v2) was pooled to perform the emulsion PCR reaction and the sequence reaction.</p></section><section id="sec9"><h3 class="pmc_sec_title">Emulsion PCR and sequencing</h3>
<p>The emulsion PCR was carried out with the Ion OneTouch 2 System and Ion Torrent PGM Hi-Q OT2 Kit (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s procedure. Template-positive Ion Sphere™ Particles were enriched with the Dynabeads MyOne Streptavidin C1 Beads (Thermo Fisher Scientific, Waltham, MA, USA) and washed with Ion OneTouch Wash Solution. This process was performed using an Ion OneTouch ES system (Thermo Fisher Scientific, Waltham, MA, USA). After the Ion Sphere Particle preparation, Massive Parallel Sequencing was carried out with Ion Torrent PGM sequencer system (Thermo Fisher Scientific, Waltham, MA, USA) using the Ion Torrent PGM Hi-Q Sequencing Kit and Ion 314v2 or 316v2 Chip (Thermo Fisher Scientific, Waltham, MA, USA), according to the established procedures.</p></section><section id="sec10"><h3 class="pmc_sec_title">Data analysis</h3>
<p>Raw sequence data analysis, including base calling, demultiplexing, alignment to the hg19 human reference genome (Genome Reference Consortium GRCh37), was performed using the Torrent Suite Software version 3.6 and subsequent versions up to 5.2 (Thermo Fisher Scientific, Waltham, MA, USA). The average depth of total coverage was set at minimum 500× and for variant calls at minimum of 100×.</p>
<p>The TS data were processed using Coverage Analysis and Variant Caller (germline low stringency) plugins available within the Torrent Suite Software version 3.6 using default analysis settings and subsequently using the version 3.6 of json parameters file associated with the <em>BRCA1</em> and <em>BRCA2</em> Ion Ampliseq Panel. The VS data were processed using Coverage Analysis and Variant Caller plugins available within the Torrent Suite Software versions from 4.0 to 5.2 and the json parameters file associated with the <em>BRCA1</em> and <em>BRCA2</em> Ion Ampliseq Panel.</p>
<p>All the variants were visually examined and verified using integrative genomics viewer (IGV) version 5.01 (<a href="http://www.broadinstitute.org/igv" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.broadinstitute.org/igv</a>) as well as by filtering out possible strand-specific errors (i.e. mutations detected exclusively in the “plus” or in the “minus” strand, but not in both DNA strands). All mutations are reported following the human genome variation society guidelines (<a href="http://www.hgvs.org/mutnomen/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.hgvs.org/mutnomen/</a>) on the basis of the coding sequences <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.3</a> and <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.3</a> for <em>BRCA1</em> and <em>BRCA2</em>, respectively. Common polymorphisms, which represent 5% in the general population, and variant of uncertain significance (VUS) or pathogenic variants were classified referring to the following databases: Breast Cancer Information Core BIC (<a href="https://research.nhgri.nih.gov/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://research.nhgri.nih.gov/</a>), Clinical Variants (<a href="https://www.ncbi.nlm.nih.gov/pubmed" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pubmed</a>), dbSNP138 (<a href="https://www.ncbi.nlm.nih.gov/projects/SNP/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/projects/SNP/</a>), ARUP (<a href="http://arup.utah.edu/database/BRCA/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://arup.utah.edu/database/BRCA/</a>), Universal Mutation Database (<a href="http://www.umd.be/BRCA1/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.umd.be/BRCA1/</a>, <a href="http://www.umd.be/BRCA2/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.umd.be/BRCA2/</a>), Leiden Open (source) Variation Database (LOVD) (<a href="http://www.lovd.nl/3.0/home" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.lovd.nl/3.0/home</a>). Unclassified variants were evaluated by the following <em>in silico</em> predictors: SIFT-PROVEAN (<a href="http://provean.jcvi.org/index.php" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://provean.jcvi.org/index.php</a>), Polyphen (<a href="http://genetics.bwh.harvard.edu/pph2/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://genetics.bwh.harvard.edu/pph2/</a>), GVGD (<a href="http://agvgd.hci.utah.edu/agvgd_input.php" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://agvgd.hci.utah.edu/agvgd_input.php</a>), Mutation taster (<a href="http://www.mutationtaster.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.mutationtaster.org/</a>), Fruit Fly Splice Predictor, NNSPLICE (<a href="http://www.fruitfly.org/seq_tools/splice.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.fruitfly.org/seq_tools/splice.html</a>), Human Splicing Finder (<a href="http://www.umd.be/HSF3/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.umd.be/HSF3/</a>), Splice Predictor (DK), NetGene2 (<a href="http://www.cbs.dtu.dk/services/NetGene2/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.cbs.dtu.dk/services/NetGene2/</a>), MaxEntScan (<a href="http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html</a>), ESEfinder3.0 (<a href="http://rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi?process=home" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi?process=home</a>). The meaning of the variants not yet reported in the literature and in the databases was established as described by <a href="#ref-26" class="usa-link" aria-describedby="ref-26">Giannini et al. (2008)</a>, according to ENIGMA criteria (<a href="https://enigmaconsortium.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://enigmaconsortium.org/</a>).</p>
<p>Concordance of the NGS results with respect to those obtained with Sanger sequencing was calculated using classifications as true positive (TP), true negative (TN), false negative (FN), or false positive (FP). Regarding specificity and negative predictive value (NPV), since these parameters are calculated considering TNs, we considered the number of wild-type bases that were called by NGS and aligned to the reference sequence.</p></section><section id="sec11"><h3 class="pmc_sec_title">Sanger sequencing</h3>
<p>A subset of clinical samples (11 samples of TS and 60 samples of VS) were sequenced for the entire coding regions by Sanger sequencing. Sequencing was performed using an ABI PRISM DyeDeoxy Terminator Cycle Sequencing Kit and an ABI 3100 Genetic Analyzer (Applied Biosystems, Warrington, UK) according to <a href="#ref-27" class="usa-link" aria-describedby="ref-27">Coppa et al. (2018)</a>.</p>
<p>The reference sequence for <em>BRCA1</em> was <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.3</a>, and the reference sequence for <em>BRCA2</em> was <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.3</a>.</p></section><section id="sec12"><h3 class="pmc_sec_title">MLPA assay</h3>
<p><em>BRCA1</em> and <em>BRCA2</em> genomic rearrangements were searched by the MLPA methodology (<a href="#ref-28" class="usa-link" aria-describedby="ref-28">Schouten et al., 2002</a>) according to the manufacturer’s instructions (MRC-Holland, Amsterdam, The Netherlands) and as described (<a href="#ref-29" class="usa-link" aria-describedby="ref-29">Buffone et al., 2007</a>; <a href="#ref-27" class="usa-link" aria-describedby="ref-27">Coppa et al., 2018</a>). Variations in peak height were evaluated comparing each sample with a normal control and by a cumulative comparison.</p></section></section><section id="sec13"><h2 class="pmc_sec_title">Results</h2>
<section id="sec14"><h3 class="pmc_sec_title">Coverage data analysis</h3>
<p>The <em>BRCA1</em> and <em>BRCA2</em> panel used in this study generates 167 amplicons that cover all targeted coding exons and exon-intron boundaries. The data coverage in 147 patients (TS and VS) showed a mean amplicon reading depth per sample ranging from 244× to 2,236×, loading 2/4 samples on chips 314v2 or eight samples on chip 316v2. An adequate number of reads mapped onto target regions has been obtained both with chip 314v2 or chip 316v2, with a mean sequencing depth and an average uniformity of coverage of 726× and 97% and 1,504× and 97%, respectively (<a href="#table-2" class="usa-link">Table 2</a>; <a href="#supp-2" class="usa-link">Table S2</a> and <a href="#supp-3" class="usa-link">S3</a>). The large increase in sequencing efficiency observed with the 316v2 chips makes the analysis of a better quality and led to a lower number of false-positive indel calls. For variant calls, we chose the threshold of a minimum average depth of 100×, although a minimum average of 80× is normally required for germline mutations (<a href="#ref-10" class="usa-link" aria-describedby="ref-10">Trujillano et al., 2015</a>) and a minimum average depth in strand bias of 30× for each strand end to end. By a critical analysis of the <em>BRCA1</em> and <em>BRCA2</em> coverage data performed on 147 samples (TS and VS) emerged that some amplicons (herein defined as lower-performance amplicons) often did not reach a minimum coverage of 100× or showed fwd/rev end to end unbalance (<a href="#table-3" class="usa-link">Table 3</a>; <a href="#fig-1" class="usa-link">Fig. 1</a>). In particular, the coverage of the AMPL225438570 <em>BRCA1</em> amplicon was &lt;100× in 61% of samples (<a href="#fig-1" class="usa-link">Fig. 1A</a>). This amplicon maps in the exon 2 of the <em>BRCA1</em> gene, containing a large A-T reach region, likely to be responsible for lower amplification efficiency. Concerning <em>BRCA2</em>, we observed five amplicons with a coverage less than 100×, whose GC content, self-annealing/hairpin formation and GC clamp issues could be responsible for low performance (<a href="#table-3" class="usa-link">Table 3</a>; <a href="#fig-1" class="usa-link">Fig. 1B</a>). The same issues may also be responsible for fwd/rev end to end unbalance observed in the following amplicons: AMPL223735053, AMPL223413081, AMPL223712774 in <em>BRCA1</em> (<a href="#fig-1" class="usa-link">Figs. 1C</a> and <a href="#fig-1" class="usa-link">1D</a>; <a href="#table-3" class="usa-link">Table 3</a>); AMPL224626553, AMPL223938117, AMPL223512592, AMPL225349438, AMPL223730984, AMPL223515418, AMPL225441321, AMPL223959719 in <em>BRCA2</em> (<a href="#fig-1" class="usa-link">Figs. 1E</a> and <a href="#fig-1" class="usa-link">1F</a>; <a href="#table-3" class="usa-link">Table 3</a>). Of note, the read depths of these amplicons did not increase proportionally with an increase in mean amplicon read depths (across 167 amplicons) per sample. No variants have been identified in lower-performance amplicons in our TS and VS samples, using Ion AmpliSeq BRCA1 and BRCA2 Panel (Life Technologies, Carlsbad, CA, USA). However, all amplicons with strand bias were carefully and visually verified with IGV and re-analyzed by Sanger sequencing that confirmed the absence of variants.</p>
<section class="tw xbox font-sm" id="table-2"><h4 class="obj_head">Table 2. Mean quality control and coverage metrics in the training set and in the validation set samples.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
</colgroup>
<thead>
<tr>
<th rowspan="1" colspan="1"></th>
<th colspan="2" rowspan="1">Chip 314 (<em>n</em> = 84)</th>
<th colspan="2" rowspan="1">Chip 316 (<em>n</em> = 63)</th>
</tr>
<tr>
<th rowspan="1" colspan="1"></th>
<th rowspan="1" colspan="1">Mean</th>
<th rowspan="1" colspan="1">SD</th>
<th rowspan="1" colspan="1">Mean</th>
<th rowspan="1" colspan="1">SD</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">Number of mapped reads</td>
<td rowspan="1" colspan="1">122,109</td>
<td rowspan="1" colspan="1">43,431</td>
<td rowspan="1" colspan="1">244,737</td>
<td rowspan="1" colspan="1">69,845</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Percent reads on target (%)</td>
<td rowspan="1" colspan="1">96</td>
<td rowspan="1" colspan="1">0.03</td>
<td rowspan="1" colspan="1">97</td>
<td rowspan="1" colspan="1">0.02</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Uniformity of base coverage (%)</td>
<td rowspan="1" colspan="1">97</td>
<td rowspan="1" colspan="1">0.02</td>
<td rowspan="1" colspan="1">97</td>
<td rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Average base coverage depth</td>
<td rowspan="1" colspan="1">726</td>
<td rowspan="1" colspan="1">266</td>
<td rowspan="1" colspan="1">1,504</td>
<td rowspan="1" colspan="1">379</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/table-2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section class="tw xbox font-sm" id="table-3"><h4 class="obj_head">Table 3. <em>BRCA1</em> and <em>BRCA2</em> lower-performance and fwd/rev end to end unbalanced amplicons.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
</colgroup>
<thead><tr>
<th rowspan="1" colspan="1">Gene</th>
<th rowspan="1" colspan="1">Id amplicon</th>
<th rowspan="1" colspan="1">GC content</th>
<th rowspan="1" colspan="1">Self-annealing</th>
<th rowspan="1" colspan="1">GC clamp</th>
<th rowspan="1" colspan="1">Hairpin formation</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="2" colspan="1"><em>BRCA1</em></td>
<td rowspan="2" colspan="1">AMPL225438570</td>
<td rowspan="1" colspan="1">fwd 43%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 36%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA2</em></td>
<td rowspan="2" colspan="1">AMPL223392219</td>
<td rowspan="1" colspan="1">fwd 41%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 27%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA2</em></td>
<td rowspan="2" colspan="1">AMPL223379892</td>
<td rowspan="1" colspan="1">fwd 22%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 36%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA2</em></td>
<td rowspan="2" colspan="1">AMPL223390724</td>
<td rowspan="1" colspan="1">fwd 41%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 39%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA2</em></td>
<td rowspan="2" colspan="1">AMPL225505032</td>
<td rowspan="1" colspan="1">fwd 46%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 36%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA2</em></td>
<td rowspan="2" colspan="1">AMPL225504179</td>
<td rowspan="1" colspan="1">fwd 33%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 36%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA1</em></td>
<td rowspan="2" colspan="1">AMPL223735053</td>
<td rowspan="1" colspan="1">fwd 38%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 48%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA1</em></td>
<td rowspan="2" colspan="1">AMPL223413081</td>
<td rowspan="1" colspan="1">fwd 46%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 28%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA1</em></td>
<td rowspan="2" colspan="1">AMPL223712774</td>
<td rowspan="1" colspan="1">fwd 48%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 39%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA2</em></td>
<td rowspan="2" colspan="1">AMPL224626553</td>
<td rowspan="1" colspan="1">fwd 24%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 50%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA2</em></td>
<td rowspan="2" colspan="1">AMPL223938117</td>
<td rowspan="1" colspan="1">fwd 31%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 39%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA2</em></td>
<td rowspan="2" colspan="1">AMPL223512592</td>
<td rowspan="1" colspan="1">fwd 25%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 46%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA2</em></td>
<td rowspan="2" colspan="1">AMPL225349438</td>
<td rowspan="1" colspan="1">fwd 38%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 42%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA2</em></td>
<td rowspan="2" colspan="1">AMPL223730984</td>
<td rowspan="1" colspan="1">fwd 50%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 41%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA2</em></td>
<td rowspan="2" colspan="1">AMPL223515418</td>
<td rowspan="1" colspan="1">fw 39%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 55%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA2</em></td>
<td rowspan="2" colspan="1">AMPL225441321</td>
<td rowspan="1" colspan="1">fw 52%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 48%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td rowspan="2" colspan="1"><em>BRCA2</em></td>
<td rowspan="2" colspan="1">AMPL223959719</td>
<td rowspan="1" colspan="1">fw 38%</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td rowspan="1" colspan="1">rev 41%</td>
<td rowspan="1" colspan="1">Yes</td>
<td rowspan="1" colspan="1">/</td>
<td rowspan="1" colspan="1">Yes</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/table-3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><figure class="fig xbox font-sm" id="fig-1"><h4 class="obj_head">Figure 1. Coverage plots of <em>BRCA1</em> and <em>BRCA2</em> lower-performance amplicons from 147 samples (TS and VS samples).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6482939_peerj-07-6661-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be8/6482939/2635531d3f4f/peerj-07-6661-g001.jpg" loading="lazy" height="432" width="738" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig-1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A, B) <em>BRCA1</em> and <em>BRCA2</em> amplicons that did not reach a minimum coverage of 100×; (C, E) percentage of <em>BRCA1</em> and <em>BRCA2</em> fwd/rev unbalanced amplicons (minimum average depth in strand bias of 30× for each strand end to end); (D, F) histogram of the mean read depth per fwd/rev end to end unbalanced amplicons in <em>BRCA1</em> and <em>BRCA2</em>. Error bars represent +/- the standard error (SE) of reads number.</p></figcaption></figure></section><section id="sec15"><h3 class="pmc_sec_title">Detection of <em>BRCA1</em> and <em>BRCA2</em> variants</h3>
<p>The TS, used to test the performance of the Ion AmpliSeq BRCA1 and BRCA2 Panel (Life Technologies, Carlsbad, CA, USA) on Ion Torrent PGM platform, contained 6 <em>BRCA1</em> and 5 <em>BRCA2</em> pathogenic variants previously identified (<a href="#table-1" class="usa-link">Table 1</a>) plus 37 benign variants known (<a href="#supp-1" class="usa-link">Table S1</a>). Data obtained by Ion Torrent PGM sequencing were blindly analyzed by the Torrent Suite Software version 3.6 using the Variant Caller plugin (germline low stringency) and subsequently the specific json file. Straightforward default analysis only identified six out of 11 <em>BRCA1</em> and <em>BRCA2</em> pathogenic variants, four indel and two SNV (<a href="#fig-2" class="usa-link">Fig. 2</a>; <a href="#supp-5" class="usa-link">Fig. S1</a>). Setting the kmer length parameter value to 11 instead of the default value 19, allowed detection of the otherwise missed <em>BRCA1</em> indel c.4964_4982del19 (p.Ser1655Tyrfs) localized at the end of exon 16 (<a href="#fig-3" class="usa-link">Fig. 3A</a>), without generating FN.</p>
<figure class="fig xbox font-sm" id="fig-2"><h4 class="obj_head">Figure 2. Representative image of read alignments visualized with IGV showing the germline mutations detected by NGS default analysis (A–F).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6482939_peerj-07-6661-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be8/6482939/b4ae07577a4b/peerj-07-6661-g002.jpg" loading="lazy" height="579" width="693" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig-2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><figure class="fig xbox font-sm" id="fig-3"><h4 class="obj_head">Figure 3. Representative image of read alignments showing the germline mutations of <em>BRCA1</em> and <em>BRCA2</em> detected by NGS analysis after minimal adjustments in the analytical pipeline of Torrent Suite Software.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6482939_peerj-07-6661-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be8/6482939/37b9a163f04c/peerj-07-6661-g003.jpg" loading="lazy" height="600" width="693" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig-3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Read alignments visualized with IGV showing the germline mutation of <em>BRCA1</em>, c.4964_4982del19 (p.Ser1655Tyrfs) and <em>BRCA2</em>, c.7921_7926delGAATTTinsAG (p.Glu2641Argfs) (A and C). On the right side of the image, representative validation of NGS data by Sanger sequencing. Germline mutations were detected in the patients but not in the control subject. Arrows indicate the position of the mutated nucleotides (B and D).</p></figcaption></figure><p>To detect the <em>BRCA2</em> complex variant c.7921_7926delGAATTTinsAG (p.Glu2641Argfs) the generation of “complex variant candidates parameter” in the Torrent Suite Software has been activated (<a href="#fig-3" class="usa-link">Fig. 3B</a>). In this way, the NGS analysis correctly identified a total of 179 variants (68 in <em>BRCA1</em> and 111 in <em>BRCA2</em>), reaching the maximum sensitivity of 98.3% (95.3% for <em>BRCA1</em> and 100% for <em>BRCA2</em>) identifying eight out 11 pathogenic variants, missing only the three <em>BRCA1</em> LGRs (<a href="#table-4" class="usa-link">Table 4</a>). NGS called eight FPs variants (seven in BRCA1 and one in BRCA2) in the 11 samples of TS in the homopolymeric regions of the genes. The positive predictive value, calculated as (TPs/TPs+ FPs), was 95.5% (89.7% for <em>BRCA1</em> and 99.1% for <em>BRCA2</em>). The panel covers 16,246 nucleotides (5,989 for <em>BRCA1</em> and 10,257 for <em>BRCA2</em>) for patient, then we covered 178,706 nucleotides (65,879 for <em>BRCA1</em> and 112,827 for <em>BRCA2</em>) in the TS. If we consider that TNs could be calculated as the total analyzed nucleotides-TPs-FPs-FNs, we could calculate a total of 178,524 TNs, that is 65,808 for <em>BRCA1</em> and 112,716 for <em>BRCA2</em>. The specificity, calculated as TN/(TN+FP), and the NPV, calculated as TN/(TN+FN), were 100% (<a href="#table-4" class="usa-link">Table 4</a>). Therefore, considering LGRs as FNs, the concordance with Sanger sequencing analysis was 100%.</p>
<section class="tw xbox font-sm" id="table-4"><h4 class="obj_head">Table 4. Performance of the NGS assay (NGS <em>vs</em> Sanger) evaluated in the training set (in brackets, values were obtained considering LGRs as FNs).</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
</colgroup>
<thead><tr>
<th rowspan="1" colspan="1"></th>
<th rowspan="1" colspan="1"><em>BRCA1</em></th>
<th rowspan="1" colspan="1"><em>BRCA2</em></th>
<th rowspan="1" colspan="1">
<em>BRCA1</em> + <em>BRCA2</em>
</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">Total variants</td>
<td rowspan="1" colspan="1">68</td>
<td rowspan="1" colspan="1">111</td>
<td rowspan="1" colspan="1">179</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Called positions per patient</td>
<td rowspan="1" colspan="1">5,989</td>
<td rowspan="1" colspan="1">10,257</td>
<td rowspan="1" colspan="1">16,246</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Total called positions</td>
<td rowspan="1" colspan="1">65,879</td>
<td rowspan="1" colspan="1">112,827</td>
<td rowspan="1" colspan="1">178,706</td>
</tr>
<tr>
<td rowspan="1" colspan="1">TP</td>
<td rowspan="1" colspan="1">61</td>
<td rowspan="1" colspan="1">110</td>
<td rowspan="1" colspan="1">171</td>
</tr>
<tr>
<td rowspan="1" colspan="1">FP</td>
<td rowspan="1" colspan="1">7</td>
<td rowspan="1" colspan="1">1</td>
<td rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td rowspan="1" colspan="1">TN</td>
<td rowspan="1" colspan="1">65,808</td>
<td rowspan="1" colspan="1">112,716</td>
<td rowspan="1" colspan="1">178,524</td>
</tr>
<tr>
<td rowspan="1" colspan="1">FN</td>
<td rowspan="1" colspan="1">0 (3)</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0 (3)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Sensitivity, TP/(TP + FN)</td>
<td rowspan="1" colspan="1">100% (95.3%)</td>
<td rowspan="1" colspan="1">100%</td>
<td rowspan="1" colspan="1">100% (98.3%)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Specificity, TN/(TN + FP)</td>
<td rowspan="1" colspan="1">100%</td>
<td rowspan="1" colspan="1">100%</td>
<td rowspan="1" colspan="1">100%</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Positive predictive value (PPV), TP/(TP + FP)</td>
<td rowspan="1" colspan="1">89.7%</td>
<td rowspan="1" colspan="1">99.1%</td>
<td rowspan="1" colspan="1">95.5%</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Negative predictive value (NPV), TN/(TN + FN)</td>
<td rowspan="1" colspan="1">100%</td>
<td rowspan="1" colspan="1">100%</td>
<td rowspan="1" colspan="1">100%</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/table-4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>All these data indicated that an appropriate setting of the analytical pipeline can affect the accuracy of a variant call.</p>
<p>This optimized pipeline was then blindly applied on the VS of 136 samples, whose genotype was unknown. We detected pathogenic variants in 30 (22%) cases, 20 in <em>BRCA1</em> (15%), 10 in <em>BRCA2</em> (7%), 1 <em>BRCA1</em> VUS, and 1 <em>BRCA2</em> VUS. All variants were confirmed by Sanger sequencing in their correct zygosity status (<a href="#table-5" class="usa-link">Table 5</a>). The remain 104 samples, negative for pathogenic variants, subjected to MLPA analysis were also negative for the presence of LGRs. Of note, one of the <em>BRCA2</em> deleterious mutations (c.72delA) was a novel disease-causing variant at exon 3, predicted to code for an early truncated protein (p.Gly25Aspfs), thus falling into class V (<a href="#ref-30" class="usa-link" aria-describedby="ref-30">Plon et al., 2008</a>; <em>ENIGMA consortium</em>: <a href="https://enigmaconsortium.org/library/general-documents/enigma-classification-criteria/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://enigmaconsortium.org/library/general-documents/enigma-classification-criteria/</a>). The novel mutation has been identified in one HBC family having a clear dominant inheritance pattern and with three cases of breast cancer before 40 years of age (<a href="#supp-6" class="usa-link">Fig. S2</a>). It has not yet been possible to perform segregation analysis in this family.</p>
<section class="tw xbox font-sm" id="table-5"><h4 class="obj_head">Table 5. <em>BRCA1</em> and <em>BRCA2</em> variants contained in the validation set.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
</colgroup>
<thead>
<tr>
<th colspan="2" rowspan="1">Variant</th>
<th rowspan="2" colspan="1">Gene</th>
<th rowspan="2" colspan="1">Effect</th>
<th rowspan="2" colspan="1">Type</th>
<th rowspan="2" colspan="1">Number of times a variant was observed</th>
</tr>
<tr>
<th rowspan="1" colspan="1">DNA</th>
<th rowspan="1" colspan="1">Protein</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">c.1360_1361delAG</td>
<td rowspan="1" colspan="1">p.Ser454Terfs</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">del</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.5062_5064delGTT</td>
<td rowspan="1" colspan="1">p.Val1688del</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">del</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.5266dupC</td>
<td rowspan="1" colspan="1">p.Gln1756Profs</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">dup</td>
<td rowspan="1" colspan="1">3</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.1462dupA</td>
<td rowspan="1" colspan="1">p.Thr488Asnfs</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">dup</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.1016dupA</td>
<td rowspan="1" colspan="1">p.Val340Glyfs</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">dup</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.3331_3334delCAAG</td>
<td rowspan="1" colspan="1">p.Glu1111Asnfs</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">del</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.4117G&gt;T</td>
<td rowspan="1" colspan="1">p.Glu1373Ter</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">SNV</td>
<td rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.1505T&gt;G</td>
<td rowspan="1" colspan="1">p.Leu502Ter</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">SNV</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.5074+1G&gt;T</td>
<td rowspan="1" colspan="1">p.?</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">SNV</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.181T&gt;G</td>
<td rowspan="1" colspan="1">p.Cys61Gly</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">SNV</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.1016dupA</td>
<td rowspan="1" colspan="1">p.Val340Glyfs</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">dup</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.5335_5335delC</td>
<td rowspan="1" colspan="1">p.Gln1779Asnfs</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">del</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.1881C&gt;G</td>
<td rowspan="1" colspan="1">(p.Val627=)</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Uncertain significance</td>
<td rowspan="1" colspan="1">SNV</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.5123C&gt;A</td>
<td rowspan="1" colspan="1">p.Ala1708Glu</td>
<td rowspan="1" colspan="1">BRCA1</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">SNV</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.9252_9255delAACAinsTT</td>
<td rowspan="1" colspan="1">p.Lys3084Asnfs</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">Complex</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.4131_4132insTGAGGA</td>
<td rowspan="1" colspan="1">p.Thr1378_Gly1712delinsTer</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">ins</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.1238_1238delT</td>
<td rowspan="1" colspan="1">p.Leu413Hisfs</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">del</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.5211_5214delTACT</td>
<td rowspan="1" colspan="1">p.Asp1737_1738delThrfs</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">del</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.5718_5719delCT</td>
<td rowspan="1" colspan="1">p.Leu1908Argfs</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">del</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c 2684_2684delC</td>
<td rowspan="1" colspan="1">p.Ala895Valfs</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">del</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.6591_6592delTG</td>
<td rowspan="1" colspan="1">p.Glu2198Asnfs</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">del</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.7007G&gt;A</td>
<td rowspan="1" colspan="1">p.Arg2336His</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">SNV</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.7008-62A&gt;G</td>
<td rowspan="1" colspan="1">p.?</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Uncertain significance</td>
<td rowspan="1" colspan="1">SNV</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.72delA</td>
<td rowspan="1" colspan="1">p.Gly25Aspfs</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">del</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">c.6275_6276delTT</td>
<td rowspan="1" colspan="1">p.Leu2092Profs</td>
<td rowspan="1" colspan="1">BRCA2</td>
<td rowspan="1" colspan="1">Pathogenic</td>
<td rowspan="1" colspan="1">del</td>
<td rowspan="1" colspan="1">1</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/table-5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="table-5fn"><p><strong>Note:</strong></p></div>
<div class="fn" id="table-5fn1"><p>Abbreviations: del, deletion; dup, duplication; ins, insertion; SNV, single nucleotide variant.</p></div>
</div></section><p>A complete <em>BRCA1</em> and <em>BRCA2</em> Sanger sequencing has been performed in 60 negative samples of VS (included in the 104 negative samples), because their higher expectation to be carrier of pathogenic mutations. As expected, Sanger sequencing not only confirmed the absence of <em>BRCA1</em> and <em>BRCA2</em> pathogenic variants, but also identified all benign variants in their correct zygosity status as detected by NGS (<a href="#supp-4" class="usa-link">Table S4</a>). The variants located in regions not covered by the respective primers have been excluded from this evaluation. Altogether, our data strongly suggest that Ion Torrent PGM and Ion AmpliSeq BRCA1 and BRCA2 Panel (Life Technologies, Carlsbad, CA, USA) represent an excellent system to be applied in the field of diagnostics with 100% of concordance and sensitivity compared to Sanger method.</p>
<p>Our study enabled us to generate a standardized diagnostic workflow useful in clinical practice to quickly screen the <em>BRCA1</em> and <em>BRCA2</em> genes (<a href="#fig-4" class="usa-link">Fig. 4</a>).</p>
<figure class="fig xbox font-sm" id="fig-4"><h4 class="obj_head">Figure 4. Workflow for analyzing <em>BRCA1</em> and <em>BRCA2</em> using NGS.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6482939_peerj-07-6661-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be8/6482939/173a90f35e46/peerj-07-6661-g004.jpg" loading="lazy" height="1133" width="747" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig-4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="sec16"><h3 class="pmc_sec_title">Cost efficiency and turn-around time</h3>
<p>In comparison to traditional Sanger-based sequencing, the NGS workflow led to a reduction in cost, analysis time, and TAT for the screening of <em>BRCA1</em> and <em>BRCA2</em> genes. Considering the routine of our laboratory, which include PCR and Sanger sequencing, we calculated that we analyzed eight samples in 30–40 days. While, with the advent of NGS methodology we can analyze eight patients in 10 days, making the results available for the clinician in 15 working days following blood sampling. Costs entailed are obviously site-dependent, we calculated a cost of about 1,500–3,000 euro/sample for <em>BRCA1</em> and <em>BRCA2</em> Sanger-based sequencing, and a consistent reduction to about 300 euro/sample with NGS.</p></section></section><section id="sec17"><h2 class="pmc_sec_title">Discussion</h2>
<p>Next-generation sequencing methods are considered a promising technology, that reduces the cost and TAT of sequencing analysis. It can also be used to analyze multiple genes in a single run, greatly simplifying the study of complex hereditary disease where Sanger sequencing is not technically or economically feasible. Hence, many molecular genetic laboratories, including ours, are starting to use routinely this technology for diagnostic purpose (<a href="#ref-31" class="usa-link" aria-describedby="ref-31">De Leeneer et al., 2011</a>; <a href="#ref-32" class="usa-link" aria-describedby="ref-32">Michils et al., 2012</a>; <a href="#ref-33" class="usa-link" aria-describedby="ref-33">Chan et al., 2012</a>; <a href="#ref-8" class="usa-link" aria-describedby="ref-8">Feliubadaló et al., 2013</a>).</p>
<p>Recently, different platforms have been validated showing a comparable quality of data and throughput capacity (<a href="#ref-18" class="usa-link" aria-describedby="ref-18">Voelkerding, Dames &amp; Durtschi, 2009</a>; <a href="#ref-19" class="usa-link" aria-describedby="ref-19">Rothberg et al., 2011</a>; <a href="#ref-21" class="usa-link" aria-describedby="ref-21">Loman et al., 2012</a>; <a href="#ref-20" class="usa-link" aria-describedby="ref-20">Wallace, 2016</a>). In this study, we validated the Ion Torrent PGM platform in combination with the ready-to-use Ion AmpliSeq BRCA1 and BRCA2 Panel (Life Technologies, Carlsbad, CA, USA), as, in our opinion, it may be a good candidate for clinical <em>BRCA1</em> and <em>BRCA2</em> sequencing. <em>BRCA</em> genes are also involved in the development of sporadic breast and ovarian tumors; and patients, carrying a germline or somatic <em>BRCA1</em>/<em>BRCA2</em> variants, may benefit from PARP inhibitors therapy (<a href="#ref-14" class="usa-link" aria-describedby="ref-14">Coleman et al., 2017</a>; <a href="#ref-15" class="usa-link" aria-describedby="ref-15">Robson et al., 2017</a>; <a href="#ref-16" class="usa-link" aria-describedby="ref-16">Oza et al., 2018</a>; <a href="#ref-17" class="usa-link" aria-describedby="ref-17">Litton et al., 2018</a>). Investigating <em>BRCA1</em> and <em>BRCA2</em> mutation status in ovarian and breast cancer tissues patients, has a key role in addressing the therapeutic choices. Several studies demonstrated that NGS could be an efficient method for detecting somatic mutations in <em>BRCA1</em> and <em>BRCA2</em> genes using DNA from formalin-fixed and paraffin-embedded (FFPE) breast and ovarian cancer tissues (<a href="#ref-34" class="usa-link" aria-describedby="ref-34">Ellison et al., 2015</a>; <a href="#ref-35" class="usa-link" aria-describedby="ref-35">Mafficini et al., 2016</a>; <a href="#ref-36" class="usa-link" aria-describedby="ref-36">Enyedi et al., 2016</a>). In our laboratory the Ion Torrent PGM platform is currently used for the routine molecular characterization of FFPE tumor tissues from colon or lung cancers patients (<a href="#ref-25" class="usa-link" aria-describedby="ref-25">Belardinilli et al., 2015</a>) with a highly satisfactory performance.</p>
<p>The accuracy of NGS approach represents an important requirement in diagnostic applications, and it strongly depends on the read depth and on the analytical pipeline (<a href="#ref-37" class="usa-link" aria-describedby="ref-37">Goldfeder et al., 2016</a>). In our tests, we achieved an acceptable sequencing depth and average uniformity of amplicons coverage in all samples. 60 of the 104 <em>BRCA1</em> and <em>BRCA2</em> negative samples, that showed a higher expectation to be carrier of pathogenic mutations (i.e. HBC with BRCAPro5.1 greater than 40%, Male Breast Cancer or HBOC cases), were also subjected to <em>BRCA1</em> and <em>BRCA2</em> Sanger sequencing. We observed 100% sensitivity and 100% concordance as well as correct estimate heterozygote and homozygote status.</p>
<p>A limit of Ion AmpliSeq BRCA1 and BRCA2 Panel (Life Technologies, Carlsbad, CA, USA) is represented by the small group of lower-performance amplicons, that either did not reach a minimum coverage of 100×, as also reported by <a href="#ref-38" class="usa-link" aria-describedby="ref-38">Pilato et al. (2016)</a>, or showed fwd/rev end to end unbalance. The mean amplicon read depth could be affected by the large A-T reach region or GC content, self-annealing/hairpin formation and/or GC clamp issues (<a href="#ref-39" class="usa-link" aria-describedby="ref-39">Yan et al., 2016</a>). We overcame these limits performing, in all samples, Sanger sequencing for the regions covered by low-performance amplicons. In addition, the presence of highly homopolymeric regions in the <em>BRCA1</em> and <em>BRCA2</em> genes and the nature of semiconductor sequencing chemistry of Ion Torrent PGM were shown to limit the correct call of indel variants in these regions (<a href="#ref-9" class="usa-link" aria-describedby="ref-9">Yeo et al., 2014</a>; <a href="#ref-40" class="usa-link" aria-describedby="ref-40">Zanella et al., 2017</a>). Nonetheless, we did not observe incorrect calls in these regions in our samples.</p>
<p>A complete clinical level analysis of <em>BRCA1</em> and <em>BRCA2</em> includes the study of LGRs. In our experience, the Ion AmpliSeq BRCA1 and BRCA2 Panel (Life Technologies, Carlsbad, CA, USA) was not feasible for analyzing copy number alteration due to the sequencing read length (range, 71–239 bp) and to the high number of FP obtained (<a href="#ref-38" class="usa-link" aria-describedby="ref-38">Pilato et al., 2016</a>). Therefore, the MLPA analysis is always required using this panel. More recently, Thermo Fisher Scientific’s developed Oncomine® BRCA Research Panel, that seems to solve all these issues (<a href="#ref-41" class="usa-link" aria-describedby="ref-41">Hirotsu et al., 2017</a>).</p>
<p>Noteworthy, we identified also a novel disease-causing mutation at exon 3 of <em>BRCA2</em> gene in one HBC family. Our results demonstrated that Torrent Suite Software with the appropriate adjustments achieved 100% sensitivity (considering LGRs as FNs) and the 100% concordance with Sanger sequencing analysis, as well as correct estimate heterozygote and homozygote status from variant frequencies.</p></section><section id="sec18"><h2 class="pmc_sec_title">Conclusions</h2>
<p>In conclusion, our study, according to other published works (<a href="#ref-8" class="usa-link" aria-describedby="ref-8">Feliubadaló et al., 2013</a>; <a href="#ref-9" class="usa-link" aria-describedby="ref-9">Yeo et al., 2014</a>; <a href="#ref-10" class="usa-link" aria-describedby="ref-10">Trujillano et al., 2015</a>), shows that NGS performed with a commercial panel (Ion AmpliSeq BRCA1 and BRCA2 Panel; Life Technologies, Carlsbad, CA, USA) is highly efficient for the detection of germline mutations in <em>BRCA1</em> and <em>BRCA2</em> genes using DNA samples from routinely available patients. Moreover, the costs of NGS technology are largely lower (about 300 Euros/patient), compared with conventional methods, with a substantial reduction (about 50%) in analysis time and TAT. In our experience, the NGS achieves a perfect sensitivity and the accuracy of Sanger sequencing, becoming an indispensable instrument for routine diagnostic testing on <em>BRCA1</em> and <em>BRCA2</em> genes.</p></section><section id="supplemental-information"><h2 class="pmc_sec_title">Supplemental Information</h2>
<section class="sm xbox font-sm" id="supp-1"><div class="caption p">
<span>Supplemental Information 1. <em>BRCA1</em> and <em>BRCA2</em> benign variants contained in the Training Set.</span><p>Variants identified by NGS</p>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (13.5KB, docx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-1</div>
</div></section><section class="sm xbox font-sm" id="supp-2"><div class="caption p">
<span>Supplemental Information 2. Sequencing depth and average uniformity of coverage in Training Set and Validation Set samples (Chip 314).</span><p>Run data of the Training and Validation samples sequenced on Ion 314 Chip.</p>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s002.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (19.2KB, docx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-2</div>
</div></section><section class="sm xbox font-sm" id="supp-3"><div class="caption p">
<span>Supplemental Information 3. Sequencing depth and average uniformity of coverage in Validation Set samples (Chip 316).</span><p>Run data of the Validation samples sequenced on Ion 316 Chip.</p>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s003.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (16.2KB, docx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-3</div>
</div></section><section class="sm xbox font-sm" id="supp-4"><div class="caption p">
<span>Supplemental Information 4. Performance of the NGS assay (NGS vs Sanger) evaluated in 60 negative samples of the Validation set.</span><p>60 <em>BRCA1</em> and <em>BRCA2</em> negative samples, with a higher expectation to be carrier of pathogenic mutations</p>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s004.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (13.3KB, docx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-4</div>
</div></section><section class="sm xbox font-sm" id="supp-5"><div class="caption p">
<span>Supplemental Information 5. Representative validation of the germline mutations detected by NGS default analysis by Sanger sequencing.</span><p>Electropherograms showing the <em>BRCA1</em> and <em>BRCA2</em> variants contained in the training set compared to a group of wild type samples. Arrows indicate the position of the mutated nucleotides.</p>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s005.png" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (3.7MB, png) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-5</div>
</div></section><section class="sm xbox font-sm" id="supp-6"><div class="caption p">
<span>Supplemental Information 6. Pedigree of the HBC family BR1270.</span><p>Proband, indicated with an arrow, is a carrier of the novel germline mutation at exon 3 of <em>BRCA2</em> gene, c.72delA, identified by NGS. This disease causing variant is predicted to code for an early truncated protein (p.Gly25Aspfs). Cancer type and age at diagnosis are reported and described as: BC, breast cancer; Pan, pancreas; CNS, central nervous system cancer; Leu, leukemia.</p>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s006.png" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (229.2KB, png) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-6</div>
</div></section><section class="sm xbox font-sm" id="supp-7"><div class="caption p"><span>Supplemental Information 7. Raw data of BRCA2 novel variant exported from Ion PGM sequencer.</span></div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s007.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (13.4KB, xlsx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-7</div>
</div></section><section class="sm xbox font-sm" id="supp-8"><div class="caption p"><span>Supplemental Information 8. Raw data of BRCA2 novel variant exported from ABI 3100 Genetic Analyzer (Applied Biosystems, Warrington, UK).</span></div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s008.ab1" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (186.6KB, ab1) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-8</div>
</div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors would like to thank Valentina Silvestri for advice on data analysis.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (IG17734 to Giuseppe Giannini; IG16933 to Laura Ottini); Ministry of University and Research, PRIN projects (Giuseppe Giannini); Istituto Pasteur-Fondazione Cenci Bolognetti (Giuseppe Giannini). Virginia Valentini is the recipient of a fellowship of the PhD Programme in Tecnologie Biomediche in Medicina Clinica, University La Sapienza. Francesca Belardinilli is the recipient of a fellowship from Fondazione Umberto Veronesi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Giuseppe Giannini, Email: giuseppe.giannini@uniroma1.it.</p>
<p>Carlo Capalbo, Email: carlo.capalbo@uniroma1.it.</p>
<p>Anna Coppa, Email: anna.coppa@uniroma1.it.</p></section><section id="sec20"><h2 class="pmc_sec_title">Additional Information and Declarations</h2>
<section id="fn-group1" class="fn-group"><h3 class="pmc_sec_title">Competing Interests</h3>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="conflict-1"><p>The authors declare that they have no competing interests.</p></div></div></section><section id="fn-group2" class="fn-group"><h3 class="pmc_sec_title">Author Contributions</h3>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="contribution-1"><p>Arianna Nicolussi conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, approved the final draft.</p></div>
<div class="fn p" id="contribution-2"><p>Francesca Belardinilli performed the experiments, approved the final draft.</p></div>
<div class="fn p" id="contribution-3"><p>Yasaman Mahdavian performed the experiments, approved the final draft.</p></div>
<div class="fn p" id="contribution-4"><p>Valeria Colicchia contributed reagents/materials/analysis tools, approved the final draft.</p></div>
<div class="fn p" id="contribution-5"><p>Sonia D’Inzeo performed the experiments, prepared figures and/or tables, approved the final draft.</p></div>
<div class="fn p" id="contribution-6"><p>Marialaura Petroni contributed reagents/materials/analysis tools, approved the final draft.</p></div>
<div class="fn p" id="contribution-7"><p>Massimo Zani contributed reagents/materials/analysis tools, approved the final draft.</p></div>
<div class="fn p" id="contribution-8"><p>Sergio Ferraro contributed reagents/materials/analysis tools, approved the final draft.</p></div>
<div class="fn p" id="contribution-9"><p>Virginia Valentini performed the experiments, approved the final draft.</p></div>
<div class="fn p" id="contribution-10"><p>Laura Ottini analyzed the data, authored or reviewed drafts of the paper, approved the final draft.</p></div>
<div class="fn p" id="contribution-11"><p>Giuseppe Giannini conceived and designed the experiments, authored or reviewed drafts of the paper, approved the final draft.</p></div>
<div class="fn p" id="contribution-12"><p>Carlo Capalbo conceived and designed the experiments, analyzed the data, authored or reviewed drafts of the paper, approved the final draft.</p></div>
<div class="fn p" id="contribution-13"><p>Anna Coppa conceived and designed the experiments, analyzed the data, authored or reviewed drafts of the paper, approved the final draft.</p></div>
</div></section><section id="fn-group3" class="fn-group"><h3 class="pmc_sec_title">Human Ethics</h3>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="addinfo-1">
<p>The following information was supplied relating to ethical approvals (i.e., approving body and any reference numbers):</p>
<p>The University Sapienza of Rome granted Ethical approval to carry out the study. (Rif.Ce:4903; Prot. n. 88/18).</p>
</div></div></section><section id="fn-group4" class="fn-group"><h3 class="pmc_sec_title">DNA Deposition</h3>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="addinfo-2">
<p>The following information was supplied regarding the deposition of DNA sequences:</p>
<p>The DNA sequence is available in the ClinVar database: SCV000854769.</p>
</div></div></section><section id="fn-group5" class="fn-group"><h3 class="pmc_sec_title">Data Availability</h3>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="addinfo-3">
<p>The following information was supplied regarding data availability:</p>
<p>The raw data is available in the <a href="#supplemental-information" class="usa-link">Supplemental Information</a>.</p>
</div></div></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="ref-25">
<span class="label">Belardinilli et al. (2015).</span><cite>Belardinilli F, Capalbo C, Buffone A, Petroni M, Colicchia V, Ferraro S, Zani M, Nicolussi A, D’Inzeo S, Coppa A, Screpanti I, Gulino A, Giannini G. Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer. Clinical Biochemistry. 2015;48(13–14):908–910. doi: 10.1016/j.clinbiochem.2015.04.003.</cite> [<a href="https://doi.org/10.1016/j.clinbiochem.2015.04.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25872148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Biochemistry&amp;title=Validation%20of%20the%20Ion%20Torrent%20PGM%20sequencing%20for%20the%20prospective%20routine%20molecular%20diagnostic%20of%20colorectal%20cancer&amp;author=F%20Belardinilli&amp;author=C%20Capalbo&amp;author=A%20Buffone&amp;author=M%20Petroni&amp;author=V%20Colicchia&amp;volume=48&amp;issue=13%E2%80%9314&amp;publication_year=2015&amp;pages=908-910&amp;pmid=25872148&amp;doi=10.1016/j.clinbiochem.2015.04.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-29">
<span class="label">Buffone et al. (2007).</span><cite>Buffone A, Capalbo C, Ricevuto E, Sidoni T, Ottini L, Falchetti M, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A, Giannini G. Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families. Breast Cancer Research and Treatment. 2007;106(2):289–296. doi: 10.1007/s10549-007-9499-6.</cite> [<a href="https://doi.org/10.1007/s10549-007-9499-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17333342/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Research%20and%20Treatment&amp;title=Prevalence%20of%20BRCA1%20and%20BRCA2%20genomic%20rearrangements%20in%20a%20cohort%20of%20consecutive%20Italian%20breast%20and/or%20ovarian%20cancer%20families&amp;author=A%20Buffone&amp;author=C%20Capalbo&amp;author=E%20Ricevuto&amp;author=T%20Sidoni&amp;author=L%20Ottini&amp;volume=106&amp;issue=2&amp;publication_year=2007&amp;pages=289-296&amp;pmid=17333342&amp;doi=10.1007/s10549-007-9499-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-22">
<span class="label">Capalbo et al. (2006a).</span><cite>Capalbo C, Ricevuto E, Vestri A, Ristori E, Sidoni T, Buffone O, Adamo B, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A, Giannini G. BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models. Annals of Oncology. 2006a;17(suppl_7):vii34–vii40. doi: 10.1093/annonc/mdl947.</cite> [<a href="https://doi.org/10.1093/annonc/mdl947" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16760289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Oncology&amp;title=BRCA1%20and%20BRCA2%20genetic%20testing%20in%20Italian%20breast%20and/or%20ovarian%20cancer%20families:%20mutation%20spectrum%20and%20prevalence%20and%20analysis%20of%20mutation%20prediction%20models&amp;author=C%20Capalbo&amp;author=E%20Ricevuto&amp;author=A%20Vestri&amp;author=E%20Ristori&amp;author=T%20Sidoni&amp;volume=17&amp;issue=suppl_7&amp;publication_year=2006a&amp;pages=vii34-vii40&amp;pmid=16760289&amp;doi=10.1093/annonc/mdl947&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-23">
<span class="label">Capalbo et al. (2006b).</span><cite>Capalbo C, Ricevuto E, Vestri A, Sidoni T, Buffone A, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A, Giannini G. Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software. European Journal of Human Genetics. 2006b;14(1):49–54. doi: 10.1038/sj.ejhg.5201511.</cite> [<a href="https://doi.org/10.1038/sj.ejhg.5201511" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16288312/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Human%20Genetics&amp;title=Improving%20the%20accuracy%20of%20BRCA1/2%20mutation%20prediction:%20validation%20of%20the%20novel%20country-customized%20IC%20software&amp;author=C%20Capalbo&amp;author=E%20Ricevuto&amp;author=A%20Vestri&amp;author=T%20Sidoni&amp;author=A%20Buffone&amp;volume=14&amp;issue=1&amp;publication_year=2006b&amp;pages=49-54&amp;pmid=16288312&amp;doi=10.1038/sj.ejhg.5201511&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-33">
<span class="label">Chan et al. (2012).</span><cite>Chan M, Ji SM, Yeo ZX, Gan L, Yap E, Yap YS, Ng R, Tan PH, Ho GH, Ang P, Lee ASG. Development of a next generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform. Journal of Molecular Diagnostics. 2012;14(6):602–612. doi: 10.1016/j.jmoldx.2012.06.003.</cite> [<a href="https://doi.org/10.1016/j.jmoldx.2012.06.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22921312/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Molecular%20Diagnostics&amp;title=Development%20of%20a%20next%20generation%20sequencing%20method%20for%20BRCA%20mutation%20screening:%20a%20comparison%20between%20a%20high-throughput%20and%20a%20benchtop%20platform&amp;author=M%20Chan&amp;author=SM%20Ji&amp;author=ZX%20Yeo&amp;author=L%20Gan&amp;author=E%20Yap&amp;volume=14&amp;issue=6&amp;publication_year=2012&amp;pages=602-612&amp;pmid=22921312&amp;doi=10.1016/j.jmoldx.2012.06.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-14">
<span class="label">Coleman et al. (2017).</span><cite>Coleman RL, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp A, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O’Malley DM, Armstrong DK, Garcia-Donas J, Swisher EM, Floquet A, Konecny GE, McNeish IA, Scott CL, Cameron T, Maloney L, Isaacson J, Goble S, Grace C, Harding TC, Raponi M, Sun J, Lin KK, Giordano H, Ledermann JA, on behalf of the ARIEL3 investigators  Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390(10106):1949–1961. doi: 10.1016/S0140-6736(17)32440-6.</cite> [<a href="https://doi.org/10.1016/S0140-6736(17)32440-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5901715/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28916367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Rucaparib%20maintenance%20treatment%20for%20recurrent%20ovarian%20carcinoma%20after%20response%20to%20platinum%20therapy%20(ARIEL3):%20a%20randomised,%20double-blind,%20placebo-controlled,%20phase%203%20trial&amp;author=RL%20Coleman&amp;author=AM%20Oza&amp;author=D%20Lorusso&amp;author=C%20Aghajanian&amp;author=A%20Oaknin&amp;volume=390&amp;issue=10106&amp;publication_year=2017&amp;pages=1949-1961&amp;pmid=28916367&amp;doi=10.1016/S0140-6736(17)32440-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-12">
<span class="label">Colicchia et al. (2017).</span><cite>Colicchia V, Petroni M, Guarguaglini G, Sardina F, Sahún-Roncero M, Carbonari M, Ricci B, Heil C, Capalbo C, Belardinilli F, Coppa A, Peruzzi G, Screpanti I, Lavia P, Gulino A, Giannini G. PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma. Oncogene. 2017;36(33):4682–4691. doi: 10.1038/onc.2017.40.</cite> [<a href="https://doi.org/10.1038/onc.2017.40" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28394338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=PARP%20inhibitors%20enhance%20replication%20stress%20and%20cause%20mitotic%20catastrophe%20in%20MYCN-dependent%20neuroblastoma&amp;author=V%20Colicchia&amp;author=M%20Petroni&amp;author=G%20Guarguaglini&amp;author=F%20Sardina&amp;author=M%20Sah%C3%BAn-Roncero&amp;volume=36&amp;issue=33&amp;publication_year=2017&amp;pages=4682-4691&amp;pmid=28394338&amp;doi=10.1038/onc.2017.40&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-24">
<span class="label">Coppa et al. (2014).</span><cite>Coppa A, Buffone A, Capalbo C, Nicolussi A, D’Inzeo S, Belardinilli F, Colicchia V, Petroni M, Granato T, Midulla C, Zani M, Ferraro S, Screpanti I, Gulino A, Giannini G. Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14. Breast Cancer Research and Treatment. 2014;148(3):629–635. doi: 10.1007/s10549-014-3196-z.</cite> [<a href="https://doi.org/10.1007/s10549-014-3196-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25395318/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Research%20and%20Treatment&amp;title=Novel%20and%20recurrent%20BRCA2%20mutations%20in%20Italian%20breast/ovarian%20cancer%20families%20widen%20the%20ovarian%20cancer%20cluster%20region%20boundaries%20to%20exons%2013%20and%2014&amp;author=A%20Coppa&amp;author=A%20Buffone&amp;author=C%20Capalbo&amp;author=A%20Nicolussi&amp;author=S%20D%E2%80%99Inzeo&amp;volume=148&amp;issue=3&amp;publication_year=2014&amp;pages=629-635&amp;pmid=25395318&amp;doi=10.1007/s10549-014-3196-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-27">
<span class="label">Coppa et al. (2018).</span><cite>Coppa A, Nicolussi A, D’Inzeo S, Capalbo C, Belardinilli F, Colicchia V, Petroni M, Zani M, Ferraro S, Rinaldi C, Buffone A, Bartolazzi A, Screpanti I, Ottini L, Giannini G. Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families. Cancer Medicine. 2018;7(1):46–55. doi: 10.1002/cam4.1251.</cite> [<a href="https://doi.org/10.1002/cam4.1251" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5773970/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29271107/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Medicine&amp;title=Optimizing%20the%20identification%20of%20risk-relevant%20mutations%20by%20multigene%20panel%20testing%20in%20selected%20hereditary%20breast/ovarian%20cancer%20families&amp;author=A%20Coppa&amp;author=A%20Nicolussi&amp;author=S%20D%E2%80%99Inzeo&amp;author=C%20Capalbo&amp;author=F%20Belardinilli&amp;volume=7&amp;issue=1&amp;publication_year=2018&amp;pages=46-55&amp;pmid=29271107&amp;doi=10.1002/cam4.1251&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-4">
<span class="label">Couch et al. (2012).</span><cite>Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, Wang X, Kirchhoff T, McGuffog L, Barrowdale D, Lee A, Healey S, Sinilnikova OM, Andrulis IL, Mulligan AM, Thomassen M, Gerdes A-M, Jensen UB, Skytte A-B, Kruse TA, Caligo MA, von Wachenfeldt A, Barbany-Bustinza G, Loman N, Soller M, Ehrencrona H, Karlsson P, Rebbeck TR, Domchek SM, Jakubowska A, Lubinski J, Jaworska K, Durda K, Zlowocka E, Huzarski T, Byrski T, Gronwald J, Cybulski C, Gorski B, Osorio A, Duran M, Tejada MI, Benitez J, Hamann U, Hogervorst FBL, van Leeuwen FE, Meijers-Heijboer HEJ, Wijnen J, Blok MJ, Kets M, Hooning MJ, Oldenburg RA, Ausems MGEM, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Jacobs C, Eeles RA, Adlard J, Davidson R, Eccles DM, Cole T, Cook J, Paterson J, Brewer C, Douglas F, Hodgson SV, Morrison PJ, Walker L, Porteous ME, Kennedy MJ, Side LE, Godwin AK, Stoppa-Lyonnet D, Castera L, Cornelis F, Mazoyer S, Leone M, Boutry-Kryza N, Bressac-de Paillerets B, Caron O, Pujol P, Coupier I, Delnatte C, Akloul L, Lynch HT, Snyder CL, Buys SS, Daly MB, Terry M, Chung WK, John EM, Miron A, Southey MC, Hopper JL, Goldgar DE, Singer CF, Rappaport C, Tea M-KM, Fink-Retter A, Hansen TVO, Nielsen FC, Arason A, Vijai J, Shah S, Sarrel K, Robson ME, Piedmonte M, Phillips K, Basil J, Rubinstein WS, Boggess J, Wakeley K, Ewart-Toland A, Montagna M, Agata S, Imyanitov EN, Isaacs C, Janavicius R, Lazaro C, Blanco I, Feliubadalo L, Brunet J, Gayther SA, Pharoah PPD, Odunsi KO, Karlan BY, Walsh CS, Olah E, Teo SH, Ganz PA, Beattie MS, van Rensburg EJ, Dorfling CM, Diez O, Kwong A, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Heidemann S, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Fiebig B, Heinritz W, Caldes T, de la Hoya M, Muranen TA, Nevanlinna H, Tischkowitz MD, Spurdle AB, Neuhausen SL, Ding YC, Lindor NM, Fredericksen Z, Pankratz VS, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Barile M, Bernard L, Viel A, Giannini G, Varesco L, Radice P, Greene MH, Mai PL, Easton DF, Chenevix-Trench G, Simard J. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers and Prevention. 2012;21(4):645–657. doi: 10.1158/1055-9965.EPI-11-0888.</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-11-0888" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3319317/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22351618/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiology,%20Biomarkers%20and%20Prevention&amp;title=Common%20variants%20at%20the%2019p13.1%20and%20ZNF365%20loci%20are%20associated%20with%20ER%20subtypes%20of%20breast%20cancer%20and%20ovarian%20cancer%20risk%20in%20BRCA1%20and%20BRCA2%20mutation%20carriers&amp;author=FJ%20Couch&amp;author=MM%20Gaudet&amp;author=AC%20Antoniou&amp;author=SJ%20Ramus&amp;author=KB%20Kuchenbaecker&amp;volume=21&amp;issue=4&amp;publication_year=2012&amp;pages=645-657&amp;pmid=22351618&amp;doi=10.1158/1055-9965.EPI-11-0888&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-31">
<span class="label">De Leeneer et al. (2011).</span><cite>De Leeneer K, Hellemans J, De Schrijver J, Baetens M, Poppe B, Van Criekinge W, De Paepe A, Coucke P, Claes K. Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations. Human Mutation. 2011;32(3):335–344. doi: 10.1002/humu.21428.</cite> [<a href="https://doi.org/10.1002/humu.21428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21305653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Human%20Mutation&amp;title=Massive%20parallel%20amplicon%20sequencing%20of%20the%20breast%20cancer%20genes%20BRCA1%20and%20BRCA2:%20opportunities,%20challenges,%20and%20limitations&amp;author=K%20De%20Leeneer&amp;author=J%20Hellemans&amp;author=J%20De%20Schrijver&amp;author=M%20Baetens&amp;author=B%20Poppe&amp;volume=32&amp;issue=3&amp;publication_year=2011&amp;pages=335-344&amp;pmid=21305653&amp;doi=10.1002/humu.21428&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-34">
<span class="label">Ellison et al. (2015).</span><cite>Ellison G, Huang S, Carr H, Wallace A, Ahdesmaki M, Bhaskar S, Mills J. A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing. BMC Clinical Pathology. 2015;15(1):5. doi: 10.1186/s12907-015-0004-6.</cite> [<a href="https://doi.org/10.1186/s12907-015-0004-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4391122/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25859162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Clinical%20Pathology&amp;title=A%20reliable%20method%20for%20the%20detection%20of%20BRCA1%20and%20BRCA2%20mutations%20in%20fixed%20tumour%20tissue%20utilising%20multiplex%20PCR-based%20targeted%20next%20generation%20sequencing&amp;author=G%20Ellison&amp;author=S%20Huang&amp;author=H%20Carr&amp;author=A%20Wallace&amp;author=M%20Ahdesmaki&amp;volume=15&amp;issue=1&amp;publication_year=2015&amp;pages=5&amp;pmid=25859162&amp;doi=10.1186/s12907-015-0004-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-36">
<span class="label">Enyedi et al. (2016).</span><cite>Enyedi MZ, Jaksa G, Pintér L, Sükösd F, Gyuris Zán, Hajdu A, Határvölgyi E, Priskin K, Haracska L. Simultaneous detection of BRCA mutations and large genomic rearrangements in germline DNA and FFPE tumor samples. Oncotarget. 2016;7(38):61845–61859. doi: 10.18632/oncotarget.11259.</cite> [<a href="https://doi.org/10.18632/oncotarget.11259" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5308695/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27533253/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Simultaneous%20detection%20of%20BRCA%20mutations%20and%20large%20genomic%20rearrangements%20in%20germline%20DNA%20and%20FFPE%20tumor%20samples&amp;author=MZ%20Enyedi&amp;author=G%20Jaksa&amp;author=L%20Pint%C3%A9r&amp;author=F%20S%C3%BCk%C3%B6sd&amp;author=Z%C3%A1n%20Gyuris&amp;volume=7&amp;issue=38&amp;publication_year=2016&amp;pages=61845-61859&amp;pmid=27533253&amp;doi=10.18632/oncotarget.11259&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-8">
<span class="label">Feliubadaló et al. (2013).</span><cite>Feliubadaló L, Lopez-Doriga A, Castellsagué E, del Valle J, Menéndez M, Tornero E, Montes E, Cuesta R, Gómez C, Campos O, Pineda M, González S, Moreno V, Brunet J, Blanco I, Serra E, Capellá G, Lázaro C. Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes. European Journal of Human Genetics. 2013;21(8):864–870. doi: 10.1038/ejhg.2012.270.</cite> [<a href="https://doi.org/10.1038/ejhg.2012.270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3722680/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23249957/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Human%20Genetics&amp;title=Next-generation%20sequencing%20meets%20genetic%20diagnostics:%20development%20of%20a%20comprehensive%20workflow%20for%20the%20analysis%20of%20BRCA1%20and%20BRCA2%20genes&amp;author=L%20Feliubadal%C3%B3&amp;author=A%20Lopez-Doriga&amp;author=E%20Castellsagu%C3%A9&amp;author=J%20del%20Valle&amp;author=M%20Men%C3%A9ndez&amp;volume=21&amp;issue=8&amp;publication_year=2013&amp;pages=864-870&amp;pmid=23249957&amp;doi=10.1038/ejhg.2012.270&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-1">
<span class="label">Foulkes (2008).</span><cite>Foulkes WD. Inherited susceptibility to common cancers. The New England Journal of Medicine. 2008;359(20):2143–2153. doi: 10.1056/NEJMra0802968.</cite> [<a href="https://doi.org/10.1056/NEJMra0802968" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19005198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20New%20England%20Journal%20of%20Medicine&amp;title=Inherited%20susceptibility%20to%20common%20cancers&amp;author=WD%20Foulkes&amp;volume=359&amp;issue=20&amp;publication_year=2008&amp;pages=2143-2153&amp;pmid=19005198&amp;doi=10.1056/NEJMra0802968&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-26">
<span class="label">Giannini et al. (2008).</span><cite>Giannini G, Capalbo C, Ottini L, Buffone A, De Marchis L, Margaria E, Vitolo D, Ricevuto E, Rinaldi C, Zani M, Ferraro S, Marchetti P, Cortesi E, Frati L, Screpanti I, Gulino A. Clinical classification of BRCA1 DNA missense variants: H1686Q is a novel pathogenic mutation occurring in the ontogenetically invariant THV motif of the N-terminal BRCT domain. Journal of Clinical Oncology. 2008;26(25):4212–4214. doi: 10.1200/JCO.2008.18.2089.</cite> [<a href="https://doi.org/10.1200/JCO.2008.18.2089" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18757339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Oncology&amp;title=Clinical%20classification%20of%20BRCA1%20DNA%20missense%20variants:%20H1686Q%20is%20a%20novel%20pathogenic%20mutation%20occurring%20in%20the%20ontogenetically%20invariant%20THV%20motif%20of%20the%20N-terminal%20BRCT%20domain&amp;author=G%20Giannini&amp;author=C%20Capalbo&amp;author=L%20Ottini&amp;author=A%20Buffone&amp;author=L%20De%20Marchis&amp;volume=26&amp;issue=25&amp;publication_year=2008&amp;pages=4212-4214&amp;pmid=18757339&amp;doi=10.1200/JCO.2008.18.2089&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-37">
<span class="label">Goldfeder et al. (2016).</span><cite>Goldfeder RL, Priest JR, Zook JM, Grove ME, Waggott D, Wheeler MT, Salit M, Ashley EA. Medical implications of technical accuracy in genome sequencing. Genome Medicine. 2016;8(1):24. doi: 10.1186/s13073-016-0269-0.</cite> [<a href="https://doi.org/10.1186/s13073-016-0269-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4774017/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26932475/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Medicine&amp;title=Medical%20implications%20of%20technical%20accuracy%20in%20genome%20sequencing&amp;author=RL%20Goldfeder&amp;author=JR%20Priest&amp;author=JM%20Zook&amp;author=ME%20Grove&amp;author=D%20Waggott&amp;volume=8&amp;issue=1&amp;publication_year=2016&amp;pages=24&amp;pmid=26932475&amp;doi=10.1186/s13073-016-0269-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-41">
<span class="label">Hirotsu et al. (2017).</span><cite>Hirotsu Y, Ooka Y, Sakamoto I, Nakagomi H, Omata M. Simultaneous detection of genetic and copy number alterations in BRCA1/2 genes. Oncotarget. 2017;8(70):114463–114473. doi: 10.18632/oncotarget.22962.</cite> [<a href="https://doi.org/10.18632/oncotarget.22962" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5777706/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29383094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Simultaneous%20detection%20of%20genetic%20and%20copy%20number%20alterations%20in%20BRCA1/2%20genes&amp;author=Y%20Hirotsu&amp;author=Y%20Ooka&amp;author=I%20Sakamoto&amp;author=H%20Nakagomi&amp;author=M%20Omata&amp;volume=8&amp;issue=70&amp;publication_year=2017&amp;pages=114463-114473&amp;pmid=29383094&amp;doi=10.18632/oncotarget.22962&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-2">
<span class="label">Kuchenbaecker et al. (2017).</span><cite>Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, McGuffog L, Evans DG, Barrowdale D, Frost D, Adlard J, Ong KR, Izatt L, Tischkowitz M, Eeles R, Davidson R, Hodgson S, Ellis S, Nogues C, Lasset C, Stoppa-Lyonnet D, Fricker JP, Faivre L, Berthet P, Hooning MJ, van der Kolk LE, Kets CM, Adank MA, John EM, Chung WK, Andrulis IL, Southey M, Daly MB, Buys SS, Osorio A, Engel C, Kast K, Schmutzler RK, Caldes T, Jakubowska A, Simard J, Friedlander ML, McLachlan SA, Machackova E, Foretova L, Tan YY, Singer CF, Olah E, Gerdes AM, Arver B, Olsson H, and the BRCA1 and BRCA2 Cohort Consortium  Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402–2416. doi: 10.1001/jama.2017.7112.</cite> [<a href="https://doi.org/10.1001/jama.2017.7112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28632866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Risks%20of%20breast,%20ovarian,%20and%20contralateral%20breast%20cancer%20for%20BRCA1%20and%20BRCA2%20mutation%20carriers&amp;author=KB%20Kuchenbaecker&amp;author=JL%20Hopper&amp;author=DR%20Barnes&amp;author=KA%20Phillips&amp;author=TM%20Mooij&amp;volume=317&amp;issue=23&amp;publication_year=2017&amp;pages=2402-2416&amp;pmid=28632866&amp;doi=10.1001/jama.2017.7112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-6">
<span class="label">Kuchenbaecker et al. (2014).</span><cite>Kuchenbaecker KB, Neuhausen SL, Robson M, Barrowdale D, McGuffog L, Mulligan AM, Andrulis IL, Spurdle AB, Schmidt MK, Schmutzler RK, Engel C, Wappenschmidt B, Nevanlinna H, Thomassen M, Southey M, Radice P, Ramus SJ, Domchek SM, Nathanson KL, Lee A, Healey S, Nussbaum RL, Rebbeck TR, Arun BK, James P, Karlan BY, Lester J, Cass I, Registry BCF, Terry MB, Daly MB, Goldgar DE, Buys SS, Janavicius R, Tihomirova L, Tung N, Dorfling CM, van Rensburg EJ, Steele L, Hansen TVO, Ejlertsen B, Gerdes A-M, Nielsen FC, Dennis J, Cunningham J, Hart S, Slager S, Osorio A, Benitez J, Duran M, Weitzel JN, Tafur I, Hander M, Peterlongo P, Manoukian S, Peissel B, Roversi G, Scuvera G, Bonanni B, Mariani P, Volorio S, Dolcetti R, Varesco L, Papi L, Tibiletti MG, Giannini G, Fostira F, Konstantopoulou I, Garber J, Hamann U, Donaldson A, Brewer C, Foo C, Evans DG, Frost D, Eccles D, Douglas F, Brady A, Cook J, Tischkowitz M, Adlard J, Barwell J, Ong K-R, Walker L, Izatt L, Side LE, Kennedy MJ, Rogers MT, Porteous ME, Morrison PJ, Platte R, Eeles R, Davidson R, Hodgson S, Ellis S, Godwin AK, Rhiem K, Meindl A, Ditsch N, Arnold N, Plendl H, Niederacher D, Sutter C, Steinemann D, Bogdanova-Markov N, Kast K, Varon-Mateeva R, Wang-Gohrke S, Gehrig A, Markiefka B, Buecher B, Lefol Cédrick, Stoppa-Lyonnet D, Rouleau E, Prieur F, Damiola F, Barjhoux L, Faivre L, Longy M, Sevenet N, Sinilnikova OM, Mazoyer S, Bonadona V, Caux-Moncoutier V, Isaacs C, Van Maerken T, Claes K, Piedmonte M, Andrews L, Hays J, Rodriguez GC, Caldes T, de la Hoya M, Khan S, Hogervorst FBL, Aalfs CM, de Lange JL, Meijers-Heijboer HEJ, van der Hout AH, Wijnen JT, van Roozendaal KEP, Mensenkamp AR, van den Ouweland AMW, van Deurzen CHM, van der Luijt RB, Olah E, Diez O, Lazaro C, Blanco I, Teulé A, Menendez M, Jakubowska A, Lubinski J, Cybulski C, Gronwald J, Jaworska-Bieniek K, Durda K, Arason A, Maugard C, Soucy P, Montagna M, Agata S, Teixeira MR, Olswold C, Lindor N, Pankratz VS, Hallberg E, Wang X, Szabo CI, Vijai J, Jacobs L, Corines M, Lincoln A, Berger A, Fink-Retter A, Singer CF, Rappaport C, Kaulich DG, Pfeiler G, Tea M-K, Phelan CM, Mai PL, Greene MH, Rennert G, Imyanitov EN, Glendon G, Toland AE, Bojesen A, Pedersen IS, Jensen UB, Caligo MA, Friedman E, Berger R, Laitman Y, Rantala J, Arver B, Loman N, Borg A, Ehrencrona H, Olopade OI. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research. 2014;16(6):3416. doi: 10.1186/s13058-014-0492-9.</cite> [<a href="https://doi.org/10.1186/s13058-014-0492-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4406179/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25919761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Research&amp;title=Associations%20of%20common%20breast%20cancer%20susceptibility%20alleles%20with%20risk%20of%20breast%20cancer%20subtypes%20in%20BRCA1%20and%20BRCA2%20mutation%20carriers&amp;author=KB%20Kuchenbaecker&amp;author=SL%20Neuhausen&amp;author=M%20Robson&amp;author=D%20Barrowdale&amp;author=L%20McGuffog&amp;volume=16&amp;issue=6&amp;publication_year=2014&amp;pages=3416&amp;pmid=25919761&amp;doi=10.1186/s13058-014-0492-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-17">
<span class="label">Litton et al. (2018).</span><cite>Litton JK, Rugo HS, Ettl J, Hurvitz SA, Gonçalves A, Lee K-H, Fehrenbacher L, Yerushalmi R, Mina LA, Martin M, Roché H, Im Y-H, Quek RGW, Markova D, Tudor IC, Hannah AL, Eiermann W, Blum JL. Talazoparib in patients with advanced breast cancer and a germline BRCA mutation. New England Journal of Medicine. 2018;379(8):753–763. doi: 10.1056/NEJMoa1802905.</cite> [<a href="https://doi.org/10.1056/NEJMoa1802905" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10600918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30110579/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Talazoparib%20in%20patients%20with%20advanced%20breast%20cancer%20and%20a%20germline%20BRCA%20mutation&amp;author=JK%20Litton&amp;author=HS%20Rugo&amp;author=J%20Ettl&amp;author=SA%20Hurvitz&amp;author=A%20Gon%C3%A7alves&amp;volume=379&amp;issue=8&amp;publication_year=2018&amp;pages=753-763&amp;pmid=30110579&amp;doi=10.1056/NEJMoa1802905&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-21">
<span class="label">Loman et al. (2012).</span><cite>Loman NJ, Misra RV, Dallman TJ, Constantinidou C, Gharbia SE, Wain J, Pallen MJ. Performance comparison of benchtop high-throughput sequencing platforms. Nature Biotechnology. 2012;30(5):434–439. doi: 10.1038/nbt.2198.</cite> [<a href="https://doi.org/10.1038/nbt.2198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22522955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Biotechnology&amp;title=Performance%20comparison%20of%20benchtop%20high-throughput%20sequencing%20platforms&amp;author=NJ%20Loman&amp;author=RV%20Misra&amp;author=TJ%20Dallman&amp;author=C%20Constantinidou&amp;author=SE%20Gharbia&amp;volume=30&amp;issue=5&amp;publication_year=2012&amp;pages=434-439&amp;pmid=22522955&amp;doi=10.1038/nbt.2198&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-35">
<span class="label">Mafficini et al. (2016).</span><cite>Mafficini A, Simbolo M, Parisi A, Rusev B, Luchini C, Cataldo I, Piazzola E, Sperandio N, Turri G, Franchi M, Tortora G, Bovo C, Lawlor RT, Scarpa A. BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing. Oncotarget. 2016;7(2):1076–1083. doi: 10.18632/oncotarget.6834.</cite> [<a href="https://doi.org/10.18632/oncotarget.6834" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4811444/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26745875/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=BRCA%20somatic%20and%20germline%20mutation%20detection%20in%20paraffin%20embedded%20ovarian%20cancers%20by%20next-generation%20sequencing&amp;author=A%20Mafficini&amp;author=M%20Simbolo&amp;author=A%20Parisi&amp;author=B%20Rusev&amp;author=C%20Luchini&amp;volume=7&amp;issue=2&amp;publication_year=2016&amp;pages=1076-1083&amp;pmid=26745875&amp;doi=10.18632/oncotarget.6834&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-32">
<span class="label">Michils et al. (2012).</span><cite>Michils G, Hollants S, Dehaspe L, Van Houdt J, Bidet Y, Uhrhammer N, Bignon Y-J, Vermeesch JR, Cuppens H, Matthijs G. Molecular analysis of the breast cancer genes BRCA1 and BRCA2 using amplicon-based massive parallel pyrosequencing. Journal of Molecular Diagnostics. 2012;14(6):623–630. doi: 10.1016/j.jmoldx.2012.05.006.</cite> [<a href="https://doi.org/10.1016/j.jmoldx.2012.05.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23034506/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Molecular%20Diagnostics&amp;title=Molecular%20analysis%20of%20the%20breast%20cancer%20genes%20BRCA1%20and%20BRCA2%20using%20amplicon-based%20massive%20parallel%20pyrosequencing&amp;author=G%20Michils&amp;author=S%20Hollants&amp;author=L%20Dehaspe&amp;author=J%20Van%20Houdt&amp;author=Y%20Bidet&amp;volume=14&amp;issue=6&amp;publication_year=2012&amp;pages=623-630&amp;pmid=23034506&amp;doi=10.1016/j.jmoldx.2012.05.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-5">
<span class="label">Ottini et al. (2013).</span><cite>Ottini L, Silvestri V, Saieva C, Rizzolo P, Zanna I, Falchetti M, Masala G, Navazio AS, Graziano V, Bianchi S, Manoukian S, Barile M, Peterlongo P, D’Amico C, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Viel A, Montagna M, Radice P, Palli D. Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy. Breast Cancer Research and Treatment. 2013;138(3):861–868. doi: 10.1007/s10549-013-2459-4.</cite> [<a href="https://doi.org/10.1007/s10549-013-2459-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23468243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Research%20and%20Treatment&amp;title=Association%20of%20low-penetrance%20alleles%20with%20male%20breast%20cancer%20risk%20and%20clinicopathological%20characteristics:%20results%20from%20a%20multicenter%20study%20in%20Italy&amp;author=L%20Ottini&amp;author=V%20Silvestri&amp;author=C%20Saieva&amp;author=P%20Rizzolo&amp;author=I%20Zanna&amp;volume=138&amp;issue=3&amp;publication_year=2013&amp;pages=861-868&amp;pmid=23468243&amp;doi=10.1007/s10549-013-2459-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-16">
<span class="label">Oza et al. (2018).</span><cite>Oza AM, Matulonis UA, Malander S, Hudgens S, Sehouli J, del Campo JM, Berton-Rigaud D, Banerjee S, Scambia G, Berek JS, Lund B, Tinker AV, Hilpert F, Vázquez IP, D’Hondt V, Benigno B, Provencher D, Buscema J, Agarwal S, Mirza MR. Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial. Lancet Oncology. 2018;19(8):1117–1125. doi: 10.1016/S1470-2045(18)30333-4.</cite> [<a href="https://doi.org/10.1016/S1470-2045(18)30333-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30026000/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncology&amp;title=Quality%20of%20life%20in%20patients%20with%20recurrent%20ovarian%20cancer%20treated%20with%20niraparib%20versus%20placebo%20(ENGOT-OV16/NOVA):%20results%20from%20a%20double-blind,%20phase%203,%20randomised%20controlled%20trial&amp;author=AM%20Oza&amp;author=UA%20Matulonis&amp;author=S%20Malander&amp;author=S%20Hudgens&amp;author=J%20Sehouli&amp;volume=19&amp;issue=8&amp;publication_year=2018&amp;pages=1117-1125&amp;pmid=30026000&amp;doi=10.1016/S1470-2045(18)30333-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-11">
<span class="label">O’Sullivan Coyne, Chen &amp; Kummar (2015).</span><cite>O’Sullivan Coyne G, Chen A, Kummar S. Delivering on the promise: poly ADP ribose polymerase inhibition as targeted anticancer therapy. Current Opinion in Oncology. 2015;27(6):475–481. doi: 10.1097/CCO.0000000000000238.</cite> [<a href="https://doi.org/10.1097/CCO.0000000000000238" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4636335/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26447876/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Opinion%20in%20Oncology&amp;title=Delivering%20on%20the%20promise:%20poly%20ADP%20ribose%20polymerase%20inhibition%20as%20targeted%20anticancer%20therapy&amp;author=G%20O%E2%80%99Sullivan%20Coyne&amp;author=A%20Chen&amp;author=S%20Kummar&amp;volume=27&amp;issue=6&amp;publication_year=2015&amp;pages=475-481&amp;pmid=26447876&amp;doi=10.1097/CCO.0000000000000238&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-7">
<span class="label">Peterlongo et al. (2015).</span><cite>Peterlongo P, Chang-Claude J, Moysich KB, Rudolph A, Schmutzler RK, Simard J, Soucy P, Eeles RA, Easton DF, Hamann U, Wilkening S, Chen B, Rookus MA, Schmidt MK, van der Baan FH, Spurdle AB, Walker LC, Lose F, Maia A-T, Montagna M, Matricardi L, Lubinski J, Jakubowska A, Gomez Garcia EB, Olopade OI, Nussbaum RL, Nathanson KL, Domchek SM, Rebbeck TR, Arun BK, Karlan BY, Orsulic S, Lester J, Chung WK, Miron A, Southey MC, Goldgar DE, Buys SS, Janavicius R, Dorfling CM, van Rensburg EJ, Ding YC, Neuhausen SL, Hansen TVO, Gerdes A-M, Ejlertsen B, Jonson L, Osorio A, Martinez-Bouzas C, Benitez J, Conway EE, Blazer KR, Weitzel JN, Manoukian S, Peissel B, Zaffaroni D, Scuvera G, Barile M, Ficarazzi F, Mariette F, Fortuzzi S, Viel A, Giannini G, Papi L, Martayan A, Tibiletti MG, Radice P, Vratimos A, Fostira F, Garber JE, Donaldson A, Brewer C, Foo C, Evans DGR, Frost D, Eccles D, Brady A, Cook J, Tischkowitz M, Adlard J, Barwell J, Walker L, Izatt L, Side LE, Kennedy MJ, Rogers MT, Porteous ME, Morrison PJ, Platte R, Davidson R, Hodgson SV, Ellis S, Cole T, Claes K, Van Maerken T, Meindl A, Gehrig A, Sutter C, Engel C, Niederacher D, Steinemann D, Plendl H, Kast K, Rhiem K, Ditsch N, Arnold N, Varon-Mateeva R, Wappenschmidt B, Wang-Gohrke S, Bressac-de Paillerets B, Buecher B, Delnatte C, Houdayer C, Stoppa-Lyonnet D, Damiola F, Coupier I, Barjhoux L, Venat-Bouvet L, Golmard L, Boutry-Kryza N, Sinilnikova OM, Caron O, Pujol P, Mazoyer S, Belotti M, Friedlander ML, Rodriguez GC, Copeland LJ, de la Hoya M, Segura PP, Nevanlinna H, Aittomaki K, van Os TAM, Meijers-Heijboer HEJ, van der Hout AH, Vreeswijk MPG, Hoogerbrugge N, Ausems MGEM, van Doorn HC, Collee JM, Diez O, Blanco I, Lazaro C, Brunet J, Feliubadalo L, Cybulski C, Gronwald J, Durda K, Jaworska-Bieniek K, Sukiennicki G, Arason A, Chiquette J, Teixeira MR, Olswold C, Couch FJ, Lindor NM, Wang X, Szabo CI, Offit K, Corines M, Jacobs L, Robson ME, Zhang L, Joseph V, Berger A, Singer CF, Rappaport C, Kaulich DG, Pfeiler G, Tea M-KM, Phelan CM, Greene MH, Mai PL, Rennert G, Mulligan AM, Glendon G, Tchatchou S, Andrulis IL, Toland AE, Bojesen A, Pedersen IS, Thomassen M, Jensen UB, Laitman Y, Rantala J, von Wachenfeldt A, Ehrencrona H, Askmalm MS, Borg A, Kuchenbaecker KB, McGuffog L, Barrowdale D, Healey S, Lee A, Pharoah PDP, Chenevix-Trench G, Friedman E. Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology Biomarkers &amp; Prevention. 2015;24(1):308–316. doi: 10.1158/1055-9965.EPI-14-0532.</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-14-0532" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4294951/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25336561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiology%20Biomarkers%20&amp;%20Prevention&amp;title=Candidate%20genetic%20modifiers%20for%20breast%20and%20ovarian%20cancer%20risk%20in%20BRCA1%20and%20BRCA2%20mutation%20carriers&amp;author=P%20Peterlongo&amp;author=J%20Chang-Claude&amp;author=KB%20Moysich&amp;author=A%20Rudolph&amp;author=RK%20Schmutzler&amp;volume=24&amp;issue=1&amp;publication_year=2015&amp;pages=308-316&amp;pmid=25336561&amp;doi=10.1158/1055-9965.EPI-14-0532&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-38">
<span class="label">Pilato et al. (2016).</span><cite>Pilato B, Pinto R, De Summa S, Petriella D, Lacalamita R, Danza K, Paradiso A, Tommasi S. BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report. Genes, Chromosomes and Cancer. 2016;55(10):803–813. doi: 10.1002/gcc.22383.</cite> [<a href="https://doi.org/10.1002/gcc.22383" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27225819/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes,%20Chromosomes%20and%20Cancer&amp;title=BRCA1-2%20diagnostic%20workflow%20from%20next-generation%20sequencing%20technologies%20to%20variant%20identification%20and%20final%20report&amp;author=B%20Pilato&amp;author=R%20Pinto&amp;author=S%20De%20Summa&amp;author=D%20Petriella&amp;author=R%20Lacalamita&amp;volume=55&amp;issue=10&amp;publication_year=2016&amp;pages=803-813&amp;pmid=27225819&amp;doi=10.1002/gcc.22383&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-30">
<span class="label">Plon et al. (2008).</span><cite>Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, Hogervorst FB, Hoogerbrugge N, Spurdle AB, Tavtigian SV, IARC Unclassified Genetic Variants Working Group  Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Human Mutation. 2008;29(11):1282–1291. doi: 10.1002/humu.20880.</cite> [<a href="https://doi.org/10.1002/humu.20880" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3075918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18951446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Human%20Mutation&amp;title=Sequence%20variant%20classification%20and%20reporting:%20recommendations%20for%20improving%20the%20interpretation%20of%20cancer%20susceptibility%20genetic%20test%20results&amp;author=SE%20Plon&amp;author=DM%20Eccles&amp;author=D%20Easton&amp;author=WD%20Foulkes&amp;author=M%20Genuardi&amp;volume=29&amp;issue=11&amp;publication_year=2008&amp;pages=1282-1291&amp;pmid=18951446&amp;doi=10.1002/humu.20880&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-3">
<span class="label">Rebbeck et al. (2018).</span><cite>Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, Olah E, Olopade OI, Solano AR, Teo S-H, Thomassen M, Weitzel JN, Chan TL, Couch FJ, Goldgar DE, Kruse TA, Palmero EIêz, Park SK, Torres D, van Rensburg EJ, McGuffog L, Parsons MT, Leslie G, Aalfs CM, Abugattas J, Adlard J, Agata S, Aittomäki K, Andrews L, Andrulis IL, Arason A, Arnold N, Arun BK, Asseryanis E, Auerbach L, Azzollini J, Balmaña J, Barile M, Barkardottir RB, Barrowdale D, Benitez J, Berger A, Berger R, Blanco AM, Blazer KR, Blok MJ, Bonadona V, Bonanni B, Bradbury AR, Brewer C, Buecher B, Buys SS, Caldes T, Caliebe A, Caligo MA, Campbell I, Caputo SM, Chiquette J, Chung WK, Claes KBM, Collée JM, Cook J, Davidson R, de la Hoya M, De Leeneer K, de Pauw A, Delnatte C, Diez O, Ding YC, Ditsch N, Domchek SM, Dorfling CM, Velazquez C, Dworniczak B, Eason J, Easton DF, Eeles R, Ehrencrona H, Ejlertsen B, Engert S, Evans DG, Faivre L, Feliubadaló L, Ferrer SF, Foretova L, Fowler J, Frost D, Galvão HCR, Ganz PA, Garber J, Gauthier-Villars M, Gehrig A, Gesta P, Giannini G, Giraud S, Glendon G, Godwin AK, Greene MH, Gronwald J, Gutierrez-Barrera A, Hahnen E, Hauke J, Hentschel J, Hogervorst FBL, Honisch E, Imyanitov EN, Isaacs C, Izatt L, Izquierdo A, Jakubowska A, James P, Janavicius R, Jensen UB, John EM, Vijai J, Kaczmarek K, Karlan BY, Kast K, KConFab Investigators. Kim S-W, Konstantopoulou I, Korach J, Laitman Y, Lasa A, Lasset C, Lázaro C, Lee A, Lee MH, Lester J, Lesueur F, Liljegren A, Lindor NM, Longy M, Loud JT, Lu KH, Lubinski J, Machackova E, Manoukian S, Mari V, Martínez-Bouzas C, Matrai Z, Mebirouk N, Meijers-Heijboer HEJ, Meindl A, Mensenkamp AR, Mickys U, Miller A, Montagna M, Moysich KB, Mulligan AM, Musinsky J, Neuhausen SL, Nevanlinna H, Ngeow J, Nguyen HP, Niederacher D, Nielsen HR, Nielsen FC, Nussbaum RL, Offit K, Öfverholm A, Ong K-R, Osorio A, Papi L, Papp J, Pasini B, Pedersen IS, Peixoto A, Peruga N, Peterlongo P, Pohl E, Pradhan N, Prajzendanc K, Prieur F, Pujol P, Radice P, Ramus SJ, Rantala J, Rashid MU, Rhiem K, Robson M, Rodriguez GC, Rogers MT, Rudaitis V, Schmidt AY, Schmutzler RK, Senter L, Shah PD, Sharma P, Side LE, Simard J, Singer CF, Skytte A-B, Slavin TP, Snape K, Sobol H, Southey M, Steele L, Steinemann D, Sukiennicki G. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Human Mutation. 2018;39(5):593–620. doi: 10.1002/humu.23406.</cite> [<a href="https://doi.org/10.1002/humu.23406" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5903938/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29446198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Human%20Mutation&amp;title=Mutational%20spectrum%20in%20a%20worldwide%20study%20of%2029,700%20families%20with%20BRCA1%20or%20BRCA2%20mutations&amp;author=TR%20Rebbeck&amp;author=TM%20Friebel&amp;author=E%20Friedman&amp;author=U%20Hamann&amp;author=D%20Huo&amp;volume=39&amp;issue=5&amp;publication_year=2018&amp;pages=593-620&amp;pmid=29446198&amp;doi=10.1002/humu.23406&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-15">
<span class="label">Robson et al. (2017).</span><cite>Robson M, Im S-A, Senkus E, Xu B, Domchek SM, Masuda N, Delaloge S, Li W, Tung N, Armstrong A, Wu W, Goessl C, Runswick S, Conte P. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. New England Journal of Medicine. 2017;377(6):523–533. doi: 10.1056/NEJMoa1706450.</cite> [<a href="https://doi.org/10.1056/NEJMoa1706450" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28578601/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Olaparib%20for%20metastatic%20breast%20cancer%20in%20patients%20with%20a%20germline%20BRCA%20mutation&amp;author=M%20Robson&amp;author=S-A%20Im&amp;author=E%20Senkus&amp;author=B%20Xu&amp;author=SM%20Domchek&amp;volume=377&amp;issue=6&amp;publication_year=2017&amp;pages=523-533&amp;pmid=28578601&amp;doi=10.1056/NEJMoa1706450&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-19">
<span class="label">Rothberg et al. (2011).</span><cite>Rothberg JM, Hinz W, Rearick TM, Schultz J, Mileski W, Davey M, Leamon JH, Johnson K, Milgrew MJ, Edwards M, Hoon J, Simons JF, Marran D, Myers JW, Davidson JF, Branting A, Nobile JR, Puc BP, Light D, Clark TA, Huber M, Branciforte JT, Stoner IB, Cawley SE, Lyons M, Fu Y, Homer N, Sedova M, Miao X, Reed B, Sabina J, Feierstein E, Schorn M, Alanjary M, Dimalanta E, Dressman D, Kasinskas R, Sokolsky T, Fidanza JA, Namsaraev E, McKernan KJ, Williams A, Roth GT, Bustillo J. An integrated semiconductor device enabling non-optical genome sequencing. Nature. 2011;475(7356):348–352. doi: 10.1038/nature10242.</cite> [<a href="https://doi.org/10.1038/nature10242" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21776081/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=An%20integrated%20semiconductor%20device%20enabling%20non-optical%20genome%20sequencing&amp;author=JM%20Rothberg&amp;author=W%20Hinz&amp;author=TM%20Rearick&amp;author=J%20Schultz&amp;author=W%20Mileski&amp;volume=475&amp;issue=7356&amp;publication_year=2011&amp;pages=348-352&amp;pmid=21776081&amp;doi=10.1038/nature10242&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-28">
<span class="label">Schouten et al. (2002).</span><cite>Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Research. 2002;30(12):e57.  doi: 10.1093/nar/gnf056.</cite> [<a href="https://doi.org/10.1093/nar/gnf056" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC117299/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12060695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Research&amp;title=Relative%20quantification%20of%2040%20nucleic%20acid%20sequences%20by%20multiplex%20ligation-dependent%20probe%20amplification&amp;author=JP%20Schouten&amp;author=CJ%20McElgunn&amp;author=R%20Waaijer&amp;author=D%20Zwijnenburg&amp;author=F%20Diepvens&amp;volume=30&amp;issue=12&amp;publication_year=2002&amp;pages=e57&amp;pmid=12060695&amp;doi=10.1093/nar/gnf056&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-13">
<span class="label">Stewart, Pilié &amp; Yap (2018).</span><cite>Stewart RA, Pilié PG, Yap TA. Development of PARP and immune-checkpoint inhibitor combinations. Cancer Research. 2018;78(24):6717–6725. doi: 10.1158/0008-5472.CAN-18-2652.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-18-2652" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30498083/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Research&amp;title=Development%20of%20PARP%20and%20immune-checkpoint%20inhibitor%20combinations&amp;author=RA%20Stewart&amp;author=PG%20Pili%C3%A9&amp;author=TA%20Yap&amp;volume=78&amp;issue=24&amp;publication_year=2018&amp;pages=6717-6725&amp;pmid=30498083&amp;doi=10.1158/0008-5472.CAN-18-2652&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-10">
<span class="label">Trujillano et al. (2015).</span><cite>Trujillano D, Weiss MER, Schneider J, Köster J, Papachristos EB, Saviouk V, Zakharkina T, Nahavandi N, Kovacevic L, Rolfs A. Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and/or ovarian cancer. Journal of Molecular Diagnostics. 2015;17(2):162–170. doi: 10.1016/j.jmoldx.2014.11.004.</cite> [<a href="https://doi.org/10.1016/j.jmoldx.2014.11.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25556971/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Molecular%20Diagnostics&amp;title=Next-generation%20sequencing%20of%20the%20BRCA1%20and%20BRCA2%20genes%20for%20the%20genetic%20diagnostics%20of%20hereditary%20breast%20and/or%20ovarian%20cancer&amp;author=D%20Trujillano&amp;author=MER%20Weiss&amp;author=J%20Schneider&amp;author=J%20K%C3%B6ster&amp;author=EB%20Papachristos&amp;volume=17&amp;issue=2&amp;publication_year=2015&amp;pages=162-170&amp;pmid=25556971&amp;doi=10.1016/j.jmoldx.2014.11.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-18">
<span class="label">Voelkerding, Dames &amp; Durtschi (2009).</span><cite>Voelkerding KV, Dames SA, Durtschi JD. Next-generation sequencing: from basic research to diagnostics. Clinical Chemistry. 2009;55(4):641–658. doi: 10.1373/clinchem.2008.112789.</cite> [<a href="https://doi.org/10.1373/clinchem.2008.112789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19246620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Chemistry&amp;title=Next-generation%20sequencing:%20from%20basic%20research%20to%20diagnostics&amp;author=KV%20Voelkerding&amp;author=SA%20Dames&amp;author=JD%20Durtschi&amp;volume=55&amp;issue=4&amp;publication_year=2009&amp;pages=641-658&amp;pmid=19246620&amp;doi=10.1373/clinchem.2008.112789&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-20">
<span class="label">Wallace (2016).</span><cite>Wallace AJ. New challenges for BRCA testing: a view from the diagnostic laboratory. European Journal of Human Genetics. 2016;24(S1):S10–S18. doi: 10.1038/ejhg.2016.94.</cite> [<a href="https://doi.org/10.1038/ejhg.2016.94" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5141576/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27514839/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Human%20Genetics&amp;title=New%20challenges%20for%20BRCA%20testing:%20a%20view%20from%20the%20diagnostic%20laboratory&amp;author=AJ%20Wallace&amp;volume=24&amp;issue=S1&amp;publication_year=2016&amp;pages=S10-S18&amp;pmid=27514839&amp;doi=10.1038/ejhg.2016.94&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-39">
<span class="label">Yan et al. (2016).</span><cite>Yan B, Hu Y, Ng C, Ban KHK, Tan TW, Huan PT, Lee P-L, Chiu L, Seah E, Ng CH, Koay ES-C, Chng W-J. Coverage analysis in a targeted amplicon-based next-generation sequencing panel for myeloid neoplasms. Journal of Clinical Pathology. 2016;69(9):801–804. doi: 10.1136/jclinpath-2015-203580.</cite> [<a href="https://doi.org/10.1136/jclinpath-2015-203580" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26896490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Pathology&amp;title=Coverage%20analysis%20in%20a%20targeted%20amplicon-based%20next-generation%20sequencing%20panel%20for%20myeloid%20neoplasms&amp;author=B%20Yan&amp;author=Y%20Hu&amp;author=C%20Ng&amp;author=KHK%20Ban&amp;author=TW%20Tan&amp;volume=69&amp;issue=9&amp;publication_year=2016&amp;pages=801-804&amp;pmid=26896490&amp;doi=10.1136/jclinpath-2015-203580&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-9">
<span class="label">Yeo et al. (2014).</span><cite>Yeo ZX, Wong JC, Rozen SG, Lee AS. Evaluation and optimisation of indel detection workflows for ion torrent sequencing of the BRCA1 and BRCA2 genes. BMC Genomics. 2014;15(1):516. doi: 10.1186/1471-2164-15-516.</cite> [<a href="https://doi.org/10.1186/1471-2164-15-516" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4079958/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24962530/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Genomics&amp;title=Evaluation%20and%20optimisation%20of%20indel%20detection%20workflows%20for%20ion%20torrent%20sequencing%20of%20the%20BRCA1%20and%20BRCA2%20genes&amp;author=ZX%20Yeo&amp;author=JC%20Wong&amp;author=SG%20Rozen&amp;author=AS%20Lee&amp;volume=15&amp;issue=1&amp;publication_year=2014&amp;pages=516&amp;pmid=24962530&amp;doi=10.1186/1471-2164-15-516&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref-40">
<span class="label">Zanella et al. (2017).</span><cite>Zanella I, Merola F, Biasiotto G, Archetti S, Spinelli E, Di Lorenzo D. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations. Experimental and Molecular Pathology. 2017;102(2):314–320. doi: 10.1016/j.yexmp.2017.03.001.</cite> [<a href="https://doi.org/10.1016/j.yexmp.2017.03.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28263838/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Experimental%20and%20Molecular%20Pathology&amp;title=Evaluation%20of%20the%20Ion%20Torrent%20PGM%20sequencing%20workflow%20for%20the%20routine%20rapid%20detection%20of%20BRCA1%20and%20BRCA2%20germline%20mutations&amp;author=I%20Zanella&amp;author=F%20Merola&amp;author=G%20Biasiotto&amp;author=S%20Archetti&amp;author=E%20Spinelli&amp;volume=102&amp;issue=2&amp;publication_year=2017&amp;pages=314-320&amp;pmid=28263838&amp;doi=10.1016/j.yexmp.2017.03.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>Supplemental Information 1. <em>BRCA1</em> and <em>BRCA2</em> benign variants contained in the Training Set.</span><p>Variants identified by NGS</p>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (13.5KB, docx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-1</div>
</div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>Supplemental Information 2. Sequencing depth and average uniformity of coverage in Training Set and Validation Set samples (Chip 314).</span><p>Run data of the Training and Validation samples sequenced on Ion 314 Chip.</p>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s002.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (19.2KB, docx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-2</div>
</div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p">
<span>Supplemental Information 3. Sequencing depth and average uniformity of coverage in Validation Set samples (Chip 316).</span><p>Run data of the Validation samples sequenced on Ion 316 Chip.</p>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s003.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (16.2KB, docx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-3</div>
</div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p">
<span>Supplemental Information 4. Performance of the NGS assay (NGS vs Sanger) evaluated in 60 negative samples of the Validation set.</span><p>60 <em>BRCA1</em> and <em>BRCA2</em> negative samples, with a higher expectation to be carrier of pathogenic mutations</p>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s004.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (13.3KB, docx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-4</div>
</div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="caption p">
<span>Supplemental Information 5. Representative validation of the germline mutations detected by NGS default analysis by Sanger sequencing.</span><p>Electropherograms showing the <em>BRCA1</em> and <em>BRCA2</em> variants contained in the training set compared to a group of wild type samples. Arrows indicate the position of the mutated nucleotides.</p>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s005.png" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (3.7MB, png) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-5</div>
</div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material6_reqid_"><div class="caption p">
<span>Supplemental Information 6. Pedigree of the HBC family BR1270.</span><p>Proband, indicated with an arrow, is a carrier of the novel germline mutation at exon 3 of <em>BRCA2</em> gene, c.72delA, identified by NGS. This disease causing variant is predicted to code for an early truncated protein (p.Gly25Aspfs). Cancer type and age at diagnosis are reported and described as: BC, breast cancer; Pan, pancreas; CNS, central nervous system cancer; Leu, leukemia.</p>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s006.png" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (229.2KB, png) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-6</div>
</div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material7_reqid_"><div class="caption p"><span>Supplemental Information 7. Raw data of BRCA2 novel variant exported from Ion PGM sequencer.</span></div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s007.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (13.4KB, xlsx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-7</div>
</div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material8_reqid_"><div class="caption p"><span>Supplemental Information 8. Raw data of BRCA2 novel variant exported from ABI 3100 Genetic Analyzer (Applied Biosystems, Warrington, UK).</span></div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/6482939/bin/peerj-07-6661-s008.ab1" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (186.6KB, ab1) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7717/peerj.6661/supp-8</div>
</div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The following information was supplied regarding data availability:</p>
<p>The raw data is available in the <a href="#supplemental-information" class="usa-link">Supplemental Information</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PeerJ are provided here courtesy of <strong>PeerJ, Inc</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.7717/peerj.6661"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/peerj-07-6661.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (5.9 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/6482939/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/6482939/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC6482939%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC6482939/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC6482939/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC6482939/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/31065452/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC6482939/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/31065452/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC6482939/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/6482939/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="UFwAJhc3teW3IkInSfbsJUjd2r2IGm7twPWNv9FBKWqnTqdo8ez2g2cT9jrVJ7CY">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
